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Abstract

THE EFFECT OF LEGAL STATUS ON RESPONSES TO BRIEF MOTIVATIONAL
INTERVIEWING WITH SUBSTANCE USERS
By Thomas Burton Moore, M.S.
A thesis submitted in partial fulfillment of the requirements for the degree of Master of
Science at Virginia Commonwealth University.
Virginia Commonwealth University, 2012
Major Director: Dace Svikis, Ph.D.
Professor of Psychology, Psychiatry, and Obstetrics/Gynecology
Department of Psychology and Psychiatry

The effectiveness of drug abuse treatment for clients coerced into care remains controversial.
Some studies find clients with legal pressure do better than those without legal pressure,
while others report the exact opposite. Opposing views are often fueled by the wide-ranging
models that guide delivery of addiction treatment. The present study examined how
participants with and without legal pressure to attend treatment responded to a motivational
(MET) vs. traditional (TAU) form of addiction treatment. Additionally, the predictive value
of the Readiness to Change (RTC) score, from the URICA, was assessed across days of
substance use and treatment retention. Legal status was shown to have a significant effect on
days of primary substance use per week and treatment retention, regardless of intervention
condition. The RTC score was shown not to be predictive of days of primary substance use
or treatment retention. Research and clinical implications and future directions are discussed.

The effect of legal status on responses to brief motivational interviewing with substance
users
Substance Use Disorders
Substance abuse and dependence affects 22.2 million Americans each year (NSDUH,
2008). The treatment of addiction and addiction-related problems continues to be a heavily
argued and discussed field. The medical and social costs of a substance use addiction of any
type are costly. In 2003 it was estimated that 21 billion dollars per year was spent on
addiction services (NSDUH, 2008), with costs associated with drug and alcohol use (i.e.
health care, lost wages, legal, etc.) accounting for a total of $500 billion annually (Jason &
Ferrari, 2010).
Prevalence and Diagnosis of Substance Use Disorders
Substance Use Disorders are present in a surprisingly large proportion of the
population and account for a significant amount of the costs associated with health care and
mental health services each year. Data from the National Epidemiological Survey on
Alcohol and Related Conditions (NESARC) conducted by the National Institute on Alcohol
Abuse and Alcoholism (NIAAA) in 2001-2002, indicated that Alcohol Use Disorders afflict
17.6 million adult Americans. These findings, derived from a national, face-to-face survey
(N=43,093), noted that alcohol use disorders (AUD) were more common among men and
younger respondents than among women and older respondents (Compton, Thomas, Stinson
& Grant, 2007). These results are consistent with an earlier study which suggested 17.4
million adult Americans suffered from AUD’s (Sobell, Sobell, & Gavin, 1995), and present
some of the most comprehensive data looking at substance use and abuse in the United
States.
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A more recent survey conducted by The Substance Abuse and Mental Health Services
Administration (SAMHSA), is the 2008 National Survey on Drug Use and Health (NSDUH).
Data for this study were collected between 2007-2008 (N=136,606) (SAMSHA, 2010). A
representative sample of 136,606 individuals aged 12 or over were interviewed in their place
of residence. According to the results of this survey 20.1 million (8%) Americans aged 12 or
over had used illicit drugs in the past month (9.3% of youths aged 12-17, 19.6% of adults
aged 18-25 and 5.9% of adults over 25), and 51.6 % (129.0 million) of persons aged 12 or
over used alcohol in the past month. A total of 23.3% (58.8 million) of people aged 12 or
over had engaged in binge drinking (5 or more drinks in the same day) in the past month.
Heavy drinking, defined as 5 or more days of binge drinking in a month, was engaged in by
6.9% of the population, or 17.3 million Americans aged 12 or over. In 18-25 year olds, the
reported rates of binge drinking and heavy drinking were 41% and 14.5%, respectively.
Substance use disorders (SUD), have a long history in the Diagnostic and Statistical
Manual of Mental Disorders, first conceptualized as sociopathic personality disturbances in
DSM-I and later personality disorders and sexual deviations in DSM-II (Nathan, Skinstad,
Langenbucher,1999). With DSM, DSM-III, and DSM-III-R, SUDs were formalized and
separated into two distinct diagnoses: Substance Abuse and Substance Dependence.
Substance Abuse was viewed as the less severe of the two disorders. Further refinements in
the criteria occurred for Substance Abuse and Dependence in the DSM-IV. According to the
DSM-IV, Substance Dependence criteria are to be applied first, then, if an individual does
not meet these criteria, a diagnosis of Substance Abuse considered. Text revisions were made
to DSM-IV in 2000 to reflect new empirical evidence and correct factual errors (APA, 2000).
Although there were refinements in the diagnostic criteria for SUDs between DSM-III-R and
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DSM-IV, these changes were not substantive. Changes included: 1) the addition of qualifiers
of “with or without physiological dependence” to the disorder of Substance Dependence; and
2) moving the criterion of social and occupational consequences of substance use from
Substance Dependence to Substance Abuse. Additional changes are planned for the DSM-V,
due out in 2012. It is uncertain if these changes will represent a major or minor change in
SUD criteria. Specific criteria for the current DSM-IV-TR Substance Dependence and
Substance Abuse diagnoses are summarized below (DSM-IV-TR, 2000).
A diagnosis of substance dependence requires demonstrating three or more of the
following; 1) tolerance, 2) withdrawal, 3) compulsive use, 4) “persistent desire or
unsuccessful efforts to cut down”, 5) increased time spent in substance seeking behaviors, 6)
continued use despite negative physical or psychological problems, and 7) social,
occupational or recreational activities given up because of substance use. Tolerance is
defined in the DSM-IV as “a need for markedly increased amounts of the substance” for
achieving the same high or “a markedly diminished effect”. Individuals diagnosed with
dependence experience withdrawal symptoms or avoid them through the use of other
substances. Compulsive use is defined as taking the substance in larger amounts over a
longer period of time than intended (DSM-IV-TR p. 181, 2000).
Substance abuse is defined according to the DSM-IV-TR as a “pattern of substance
use leading to clinically significant impairment or distress” in one or more of four criteria
and never meeting the criteria for Substance Dependence. Substance use has resulted in 1)
“failure to fulfill major role obligations at work, school, or home”, 2) is the “recurrent use of
the substance in situations in which it is physically hazardous”, 3) is “recurrent substancerelated legal problems”, 4) “continued substance use despite having persistent or recurrent
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social or interpersonal problems caused or exacerbated by the effects of the substance”
(DSM-IV-TR p. 182-183, 2000). Meeting one or more of the above criteria is enough to
meet criteria for a Substance Abuse diagnosis.
It is estimated that 8.9% (22.2 million) of Americans met classification for substance
abuse or dependence in the past year. Of this population, 3.1 million were classified with
dependence or abuse of both alcohol and illicit drugs, 3.9 million were dependent or abusing
illicit drugs but not alcohol, and 15.2 million were dependent or abusing alcohol but not
illicit drugs (NSDUH, 2008). There is no indication of a change in prevalence between 2002
and 2008 (22.0 million in 2002 and 22.2 million in 2008) (NSDUH, 2008). In 2008, it is
estimated that 23.1 million persons aged 12 and above were in need of treatment for illicit
drug and/or alcohol use problems. Of this 23.1 million, only 2.3 million received treatment,
meaning that 20.8 million people in need of treatment had not received any specialty
treatment at a substance abuse facility in the past year. Of those that did not receive
treatment 1.0 million (4.8%) felt that they needed treatment, with 23.3% (233,000) of this
sub-group making an effort to get treatment, and 76.7% (766,000) making no effort to get
treatment (NSDUH 2008).
The substance abuse literature continues to support that substance use disorders are a
chronic, relapsing condition. Despite this, outside the substance abuse literature, these
disorders consistently are conceptualized as a social problem, because of the effects on social
systems (legal problems, lost work, etc.). This view holds that substance dependence is
primarily a social problem requiring prohibition and legal enforcement rather than a health
problem that requires prevention and treatment. It is likely that this “SUDs as a social
problem” perspective is held and maintained because 40% to 60% of patients treated for
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alcohol or other drug dependence return to active substance use within a year following
treatment discharge (McLellan & McKay, 1998; Finney & Moos, 1992). According to
McLellan, Lewis, O’Brien, Kleber (2000), viewing drug and alcohol dependence as a
curable, acute condition supports this social problem view. However, if a chronic illness
model is adopted for SUDs, the standards for treatment and outcome expectations would be
found among other chronic illnesses such as type 2 diabetes mellitus, hypertension, and
asthma (McLellan et al., 2000). With these chronic conditions, as with substance abuse,
there is a high relapse of symptoms when treatment is withdrawn.
It is important to recognize that in the population of over 23 million Americans who
were in need of treatment, only 10% received this treatment (NSDUH, 2008). There are
several possible reasons why this is the case, some include, the inability to access services,
lack of resources to pay for services, belief that treatment services do not work and stigma
associated with seeking out these services.
Conceptualization of substance abuse by professionals in the field has changed
considerably in the last thirty years, however, the general population has been slow to catch
up. Many still hold views about substance abuse that are outdated, and in many cases have
been shown to be erroneous. One such perspective is that substance use is a weakness of
character, that abuse problems are the fault of the individual for engaging in "immoral" drugseeking behavior. As a result, the traditional social mechanism for controlling immoral
behavior results in the criminal sanctioning of this behavior, and the person committing the
behavior (Fingarette, 1989). Another such view, popularized by twelve step programs,
asserts that before a person can make a change in their behaviors they must hit their lowest
point (i.e., “rock bottom”). It is this lowest point that provides the motivation for all future
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actions to avoid substances (Fingarette, 1989). Another more nuanced stance, is that
substance abuse is static and unchanging, and that attitudes toward substance use are also
static and unchanging. This view, and the others briefly described run contrary to the most
recent and empirically supported models of substance use. The Transtheoretical stages of
change model and Self determination theory are both examples of such, and will be discussed
more fully as a way of understanding substance use and the effectiveness of a motivational
approach to treatment of substance use.
Transtheoretical Model of Change
A diagnosis of substance abuse or dependence is an important way to categorize
substance users, and it has been discussed in great detail, however it provides little
information for the way in which we conceptualize the process of change from substance
user to recovery. The most prevalent and widely held way of conceptualizing this process of
change is through the use of the transtheoretical model of change (Prochaska & DiClemente,
1983). This model includes three dimensions representing critical elements of the change
process: stages, processes, and levels of change (Prochaska, DiClemente & Norcross, 1992).
Stages are a representation of the temporal and motivational aspects of change. This process
is the mechanism that facilitates the movement through the stages. The five levels of change
are, precontemplation, contemplation, preparation, action, and maintenance. Though not
initially included as a stage of change, relapse is now conceptualized as a unique part of the
stages of change. The stages of change can be thought of as a series of steps through which
substance abusers traverse. Precontemplation is when there is no thought given for changing,
contemplation is the consideration of change (weighing of the pros and cons), preparation is
the commitment and planning to change, action is the modification of behaviors, and
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maintenance is when the substance abuser sustains the changes made. Change is presented in
a sequential pathway from precontemplation to maintenance; however change rarely occurs
so simply or neatly. Often change is characterized by regression, relapse and repetition of
stages (DiClemente, 1999).
Progress

Precontemplation
Contemplation
Preparation
Action
Maintenance

Relapse

Adapted from Prochaska & DiClemente 1983.
Figure 1. Transtheoretical Model of Change.
Self Determination Theory (SDT)
The Transtheoretical Model of Change represents a way that recovery from substance
use is conceptualized. A second important theory that is essential to the understanding of
Motivational Interviewing is Self Determination Theory (SDT). This theory is a broad
framework for the study of human motivation and personality. Within SDT, intrinsic and
extrinsic sources of motivation, are defined and the respective roles of intrinsic and extrinsic
motivation are described in cognitive and social development, and in individual differences.
Three conditions are identified that support an individual’s experience; autonomy,
7

competence and relatedness (Ryan & Deci, 2000). Self Determination Theory also proposes
that the degree to which any of these three psychological needs is unsupported or undermined
within a social context will have a detrimental impact on wellness in that setting. This
framework has broad implications for understanding the practices that enhance, versus
diminish functioning of the individual (Ryan & Deci, 2000).
Self Determination Theory can be utilized as a theoretical framework for
understanding the role and nature of motivation in substance abuse treatment. According to
SDT, individuals have a psychological need for autonomy. Undermining personal autonomy
makes them feel as if their behavior is coerced, which reduces their interest and motivation to
engage (in treatment). The application of SDT to substance abuse treatment predicts that the
perception of pressure to enter or remain in treatment that is exerted by an external sources
can be perceived as undermining autonomy. This theory supports the use of treatment and
treatment engaging services that seek to enhance patient motivation to engage in treatment,
thereby reducing external pressure and enhancing autonomy.
Motivation has been conceptualized in many different ways, with the majority of
researchers and health care professionals treating motivation as something that varies in
amount, and therefore, trying to identify and explore conditions that enhance or decrease
motivation. While SDT acknowledges the importance of this distinction, the theory goes
further by considering that people can be moved into action by a number of different forces,
ranging from self-determined inwardly endorsed motives, including personal interests
(intrinsic motivation), to external and controlling forces that pressure the individual to
behave in a certain way (extrinsic motivation). Considering these forces, SDT has been able
to identify six distinct types of motivation, ranging from intrinsic motivation to external
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motivation (i.e., external regulation, introjections, identification and integration) and
amotivation. Each of these motivational types is theorized to result in different outcomes,
even when the level of motivation is high (Ryan & Deci, 2000; Williams, Saizow, & Ryan,
1999).
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OR

(Ryan & Deci, 2000).
Figure 2. Self Determination Theory
A major obstacle identified in the treatment of substance abusers is the lack of
motivation or ambivalence toward treatment (Miller & Rollnick, 2002; Battjes, Onken, &
Delany, 1999). Assessing motivation presents a significant challenge, especially when the
many factors and influences on a person’s motivation (e.g. internal thoughts, external forces)
are taken in to account. There is a large body of research to support the importance of
motivation in treatment seeking behaviors, treatment engagement, retention and treatment
outcomes (Neff & Zule, 2002; De Leon, Melnick, & Kressel, 1997; Lemke & Moos, 2002).
10

Currently, there is not a standardized terminology to describe the variety of complex
and nuanced motivations for treatment. Terminology such as coerced (Wild, 2006; Klag,
O’Callaghan, & Creed, P., 2005; Sullivan et al., 2008), mandated (Wild, 2006),
institutionally pressured (Polcin & Beattie, 2006), externally motivated (De Leon et al.,
2001) and socially controlled (Wild, 2006) permeate the literature. According to Wild
(2006), this lack of consistent and agreed upon definitions has allowed researchers to operate
under the assumption that referral source adequately assesses the motivation into treatment.
Wild (2006), goes on to argue that in order to truly understand motivation, the referral source
and client perceptions must be independently measured. This argument has merit as it seeks
to provide and understand the more nuanced view of treatment engagement, however, it only
breaches the surface of the complexity. Future research may benefit from utilizing this more
intricate understanding of motivation, however, current and past studies have focused solely
on method of treatment entry (i.e. legally mandated vs. non-mandated).
Motivation is generally broken into as two distinct types: intrinsic and extrinsic.
These types of motivation are in reference to the origin of the individuals desire to engage in
a particular behavior or treatment (Curry, Wagner & Grothaus, 1990). Intrinsic motivation is
generally defined as behaviors and desires which are internal to the person (Deci & Ryan,
1985). On the other hand, extrinsic motivation refers to “perceived outside pressures or
coercions to change, or to enter and/or remain in treatment” usually through legal, health,
family or employment pressures (De Leon et. al., 2001, p. 145). Wild (2006), identifies 3
types of social pressure which he defines as social control strategies; legal (i.e. drug court,
probation, etc.), formally initiated (i.e. outside the legal system but still including
institutional strategies for facilitating treatment), and informal social controls (persuasive
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interpersonal tactics). It is important to acknowledge that legal coercion is not the only type
of social pressure and can be conceptualized as one of three large categories. Despite this,
both intrinsic and extrinsic motivations can effect an individual’s participation in treatment
with the majority of research into extrinsic motivation focusing on legal pressures.
Treatment for substance abuse involves meeting the needs of voluntary and mandated
clients, and for people who may be extrinsically motivated into treatment, raising their
motivation for treatment (Lincourt, Kuettel, & Bombadier, 2002). There is evidence to
support that people’s perceptions of having choice, control and, self-determination over their
behaviors perform better, are more persistent (Deci & Ryan, 1991; Sheldon, Ryan,
Rawsthorne, & Ilardi, 1997) and are more motivated and interested in substance abuse
treatment (Koestner & Losier, 1996; Wild, Enzle, Nix, & Deci, 1997).
Motivational Interviewing
Motivational Interviewing (MI) was developed in a parallel manner to the
transtheoretical model of change. While MI was not ‘based’ on this model, both MI and the
transtheoretical model of change identified that the substance use was not a static construct.
Substance use is not a constant and unchanging behavior, instead it is a dynamic process
through which people progress. This understanding of progression and movement within
stages allowed for the development of interventions that sought to move people through
stages and facilitate the already present changing nature of substance use (Miller & Rollnick,
2009).
Motivational Interviewing was first presented by Miller and Rollnick (1991) in
"Motivational Interviewing, Preparing people for change". They define MI as a “directive,
client centered counseling style for eliciting behavior change by helping clients to explore
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and resolve ambivalence” (Miller & Rollnick, 1991, pp. 25). Further, Motivational
Interviewing is described as a skillful clinical method, and style of counseling and
psychotherapy rather than a set of techniques. Motivational Interviewing can employ a
number of specific tasks/exercises but is not solely classifiable by these techniques. Instead
MI stresses the importance of collaboration between the therapist and the client (Miller &
Rollnick, 2002). According to Miller and Rollnick (2002), an underlying motivational spirit
to MI encompasses several key ideas, including collaboration, evocation, and autonomy.
The collaborative relationship between practitioner and client is an integral
component of any MI-based intervention. This relationship actively avoids the authoritarian
stance employed in many treatment seeking relationships, and instead encourages a partnerlike relationship. Each individual (both the clinician and the client) brings specific expertise
to the treatment. This creates a positive, not coercive, interpersonal atmosphere that is
conducive to change.
Through the process of evocation, the therapist helps to elicit information or feelings
from the client. In the spirit of the collaborative relationship in MI, the therapist avoids the
role of imparting, instilling or installing, and instead works with the individual to identify
their own motivation. To be effective, the relationship requires the drawing out of
motivation from the individual. Miller and Rollnick (1991), also express the importance of
finding intrinsic motivation for change within the individual and evoking it from the person.
A final core component to the ‘spirit’ of MI is autonomy. Responsibility for change
lies within the client. The individual client must present the motives and arguments for
change. They cannot be made to do anything or forced to change, if there is any hope of long
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term or internal change. This type of therapeutic intervention is self direction of the client,
by the client, and for the client.
Four general principles are integral to MI: expression of empathy, development of
discrepancy, rolling with resistance, and supporting self-efficacy. While several exercises
can be used to demonstrate these principles, the exercises do not define them. Expression of
empathy is a fundamental and defining characteristic of MI. Founded on Carl Rogers’s work
of reflective listening and accurate empathy (Hettema, Steele, & Miller, 2005) this skill is
utilized throughout the entire MI encounter. It is through empathy that the counselor can
achieve understanding of the client without judgment, criticism or blame. Expressing
empathy does not require agreement with the client’s reporting, only acceptance by the
clinician that the client’s perspective is a valid view point within the client’s personal
framework, regardless of whether the same perspective is held by the therapist. As Miller
and Rollnick say, this “attitude of acceptance and respect builds a working therapeutic
alliance and supports the client’s self-esteem, which further promotes change” (Miller &
Rollnick, 2002, pp. 37).
Motivational Interviewing encourages an intentionally directive approach. The
development of discrepancy is the means by which the therapist attempts to help amplify
discrepancies between a client’s present state, and how they want to be. The clinician may
also amplify the differences between the client’s behaviors and their broader goals and
values. The challenge for the clinician in developing discrepancy is that there may be such
an enormous gap between where a client is, and where they want to be, that this discrepancy
actually becomes de-motivational. Generally, when developing discrepancy, the client is
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prompted to identify reasons for change. Having the client report on personal motivation for
change is more effective than the clinician saying it for them.
Many traditional substance abuse treatment models identify client resistance as
“denial”. This therapeutic hurdle usually triggers a therapist to advocate for change, while
the client advocates equally as loud, or louder, for the status quo. Conversely, MI stresses
that therapists must “roll with resistance” in an effort to reframe client resistance and move
toward the direction of change. The therapist’s role is not to provide answers, but to help
elicit answers from the client. The client is identified as the expert on themselves, and as
such, they are in possession of important insight and solutions to their own problems.
The final principle of MI is the support of self-efficacy. Self-efficacy is the
enhancement of an individual’s confidence to succeed, identify and manage their own
problems, and successfully develop solutions to these problems. Support comes from the
therapist’s belief in the client and his/her intrinsic ability to make changes. It is important to
remember that it is not the therapist doing the change. The therapist is affirming the client’s
ability and providing a voice of encouragement. For example, being supportive of changes in
behavior that the client is willing to make.
Motivational Enhancement Therapy (MET)
Motivational Enhancement Therapy (MET) is the systematic implementation of the
principles of MI and Prochaska and DiClemente’s (1983), Stages of Change theory. It is
designed to produce rapid, internally-motivated change. Motivational Enhancement Therapy
(Miller & Rollnick, 1991; Miller et al., 1992) incorporates elements found in successful brief
intervention strategies, summarized by the acronym FRAMES: Feedback regarding personal
risk, negative consequences, or impairment related to substance use; emphasis on personal
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Responsibility to change; the provision of clear Advice to change; presentation of a Menu of
change options; an Empathic therapist style; and facilitation of the patient’s Self-efficacy.
Motivational Enhancement Therapy is a manualized treatment that was developed,
using MI principles, for Project MATCH, one of the largest studies to date looking at
multiple treatments for alcohol problems (Project MATCH Research Group, 1997a,b, 1998).
Project MATCH was a multi-site, randomized clinical trial conducted at ten sites across the
U.S., which sought to compare Twelve-step Facilitation Therapy (TSF), an approach based
on the principles of Alcoholics Anonymous; Cognitive-behavioral Coping Skills Therapy
(CBT), an approach based on social learning theory; and Motivational Enhancement Therapy
(MET), a less intensive form of therapy based on the principles from Motivational
Interviewing. MET was developed and manualized from the underlying MI intervention in
order to ensure fidelity of the intervention across participating sites.
Project MATCH found that the three interventions (TSF, CBT and MET) were
equally effective at decreasing alcohol consumption and days drinking, even though TSF and
CBT were delivered over 12 weekly sessions, compared to 4 MET intervention sessions over
a twelve week period. MET was found to be a significantly briefer intervention with
outcomes consistent with more intensive and ‘established’ treatments. Additionally, better
outcomes were noted for clients with lower “readiness to change” (i.e. pre-contemplation,
contemplation) in terms of the transtheoretical stages of change stages model (described
previously) with MET than with CBT, whereas the reverse would apply to those who had
reached the action stage of change (Project MATCH Research Group, 1997a).
The MET intervention was slightly modified for the recent CTN004 protocol, to,
consist of three carefully planned sessions. Session one is described as focused on reviewing
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an individualized Personal Feedback Report, which is created through summarization of
objective information and client report at intake, and serves as a means of summarizing the
client’s view of substance-related problems, consequences, and reasons for quitting The
second and third sessions are then focused on discussing plans for changing substance use
(Carroll et al., 2002).
Prevalence Rates Among Correctional Populations
Among correctional populations a disproportionate number of individuals with
substance use disorders exist. These numbers can be seen to reflect the “War on Drugs”
mentality of the United States law enforcement system (Miller & Carroll, 2006).
Correctional populations include a variety of individuals who are involved with the
correctional system at any level, including people who are incarcerated or received a deferred
judgment, probation or parole. In their review of substance abuse among men and women
entering prison, Fazel, Bains & Doll (2006), found prevalence rates many orders of
magnitude higher than in the general population, with estimates of alcohol abuse and
dependence rates for male prisoners ranging from 18 to 30% , and in female prisoners
ranging from 10 to 24%. Drug abuse and dependence rates ranged from 10 to 48% in male
prisoners and 30 to 60% in female prisoners (Fazel, Bains & Doll, 2006).

These numbers

are considerably higher than the estimated 11.9% of males and 6.1 % of females with
substance abuse and dependence, in the general population (SAMHSA, 2010b).
The National Criminal Justice Treatment Practices (NCJTP), a national survey of
adult offenders in prisons, jails and community correctional agencies, estimates that 7 million
(BJS, 2004) to 8 million (Taxman, Young, Wiersema, Rhodes, & Mitchell, 2007) adults are
under correctional control. Of those, probationers accounted for 75% to 85% of all persons
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under correctional control in 2005 (Taxman, Perdoni, & Harrison, 2007). According to the
Bureau of Justice Statistics there were 3,296,513 men and women on probation at the state or
federal level as of 1/1/1998. In 1998, the number of individuals on probation increased by
3.7% to 3,417,613 (BJS, 1998). By 2008, the rates of probationers had risen to 4,270,917,
with parolees accounting for an additional 828,169 individuals, totaling nearly 5.1 million
individuals under correctional control in community supervision settings (BJS, 2009).
While on probation, many offenders continue to use illegal substances. Isaac, Heatley
& Savoie (1998), found that 36% of probationers and parolees tested positive for illicit
substances, 43% percent had used some type of illicit drug the past year, and 28% had used
an illicit drug within the past month. The most common illicit drug used was marijuana; 23%
of probationers had used it within the past month. Cocaine (9%), psychotherapeutics (6%),
and hallucinogens (5%) were the next most commonly used illicit drugs. These drugs, as well
as most other illicit drugs, were used at much higher rates among probationers than they were
among the general population. (Brittingham, Schildhaus, & Gfroerer, 1999))
Studies have shown that without treatment, substance-abusing offenders will
invariably repeat the same types of behaviors that led to their criminal justice status
(Harrison, 2001). Among the nearly 300,000 prisoners released in 15 states in 1994, 67.5%
were rearrested within 3 years and 51.8% were back in prison (Langan & Levin, 2002).
Approximately half of those who ended up back in prison did so for technical parole
violations (e.g., failing a drug test and missing an appointment with their parole officer). The
Drug Abuse Treatment Outcome Study (DATOS) found that more than 42% of the clients
enrolled in publicly funded drug abuse treatment programs were from the criminal justice
system (Craddock, Rounds-Bryant, Flynn, & Hubbard, 1997). It is likely that the number of
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offenders engaging in community treatment drug abuse programs has risen since this study
was conducted, however, more current data are unavailable. Offenders tend to participate in
traditional community outpatient programs that consist of drug education and counseling
services. There is considerable focus on increasing treatment services received, with much
less discussion about how to provide these services effectively (Craddock, Rounds-Bryant,
Flynn, & Hubbard, 1997).
Existing Approaches with Substance Use in Correctional Populations
There are a number of programs and approaches that address substance use in
correctional populations. One such program is probation and parole. Through this
mechanism, former prisoners are released from prison and are required to adhere to strict
behavioral guidelines, including abstinence from illicit substances. If they are unable to
remain abstinent they receive harsh sanctions or return to prison. These programs operate
under the general principle that by providing negative incentives for using that these
behaviors will not happen (Lawrence, 2008).
Another approach available for correctional populations is jail based substance abuse
treatment, often times focusing on twelve step substance abuse support. These programs
operate in many prisons and are a way for individuals who are trying to remain abstinent
from substances can receive peer support to maintain their abstinence (Hedden, Guard, &
Arndt, 2011).
An additional program that seeks to address specific treatment needs of correctional
populations is drug court. Drug Courts, first introduced in 1989, have been utilized as a
means of diverting substance offenders from the traditional court system into a specific Drug
Court system which utilizes sanctions (Wilson, Mitchell & MacKenzie, 2006). In this system
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an offender is mandated to treatment, monitored by the court system and has sanctions
enacted. Sanctions are enacted for substance use relapse, failure to attend treatment or for
other infractions (Wilson, Mitchell & MacKenzie, 2006). These programs are currently
utilized, or have plans to be enacted, in 50 states, the District of Colombia, Puerto Rico, and
over 70 tribal locations (Madras, 2010).
Use of Drug Court programs attempts to tailor how substance abusers are managed
within the criminal justice system, with different management dependent on the individual’s
needs. Still numerous gaps remain in appropriate and effective treatment for mandated
clients. It is still unknown if there are differences in effectiveness of treatment for
populations that seek substance abuse services with or without legal motivation. Other
informational gaps include questions regarding if mandated individuals will respond more
favorably, with decreased substance use, than more traditional treatment seeking populations.
MI/MET Research
Motivational Interviewing and MET have substantial research literature supporting
their efficacy and establishing their role as an Evidence Based Practice (EBP). In addition to
being supported in the literature, they have also been established as brief interventions (BI)
designed to enhance an individual’s motivation to change problem behaviors. A significant
research base exists supporting the efficacy of MI with a variety of substance using
populations, including: cocaine (Stotts, Schmitz, Rhoades, & Grabowski, 2001), heroin
(Saunders, Wilkinson & Phillips, 1995; Ward, Mattick & Hall, 1992), marijuana (The
Marijuana Treatment Project Research Group, 2004; Stephens, Roffman & Curtin, 2000) and
multiple substances (Carroll, Libby, Sheehan, 2001; Martino, Carroll, Malley, &

20

Rounsaville, 2000). Additionally, MI/MET represents one of the primary EBP’s for
treatment of substance use disorders.
Motivational Interviewing was initially conceptualized for use with alcohol related
disorders and as such, has a substantial research base with this population (Brown & Miller,
1993; Bien, Miller, & Tonigan, 1993; Miller & Rollnick, 2002). In their study looking at the
impact of MI on treatment participation and post-treatment alcohol consumption, Brown and
Miller (1993), found a significant beneficial effect. In this study, participants were
randomized to treatment as usual (TAU) or a two session MI assessment and interview at
intake in addition to standard treatment procedures. Therapist rating of patient treatment
involvement was shown to be significantly higher for the MI intervention group. There was
also a significant treatment effect at post treatment (3-month follow up), showing that the MI
group achieved more favorable outcomes (64% less substance use compared to 29% in the
control group). While the three month follow up period was not a long enough period to
establish if there were enduring effects on drinking behavior, it is suggestive of a positive
long-term outcome.
In the original multi-site clinical trial (Ball et al., 2007) from which this secondary
data analysis was carried out, 461 adults who abused substances were randomized to receive
either MET as adjunct to Treatment as Usual (TAU) or TAU alone (i.e., standard treatment).
Findings from the study showed a significant reduction in substance use across both
interventions during the 4-week therapy phase. Post-intervention, MET sustained these
reductions while CAU showed a significant increase in substance use over this same follow
up period. Study findings supported the superior treatment effects of MET in a real world
setting across 5 treatment sites.
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Utilization of the skills or “spirit” of MI is integral to the successful administration of
MI. A study comparing three treatment approaches: confrontational, client centered, and
control (treatment as usual), found that the client centered approach (which adhered closely
to MI) was significantly more effective at reducing substance use than the control or
confrontational groups (Miller, Benefield, & Tonigan, 1993). These effects were present at
both 6 weeks post treatment and, through collateral report, at 12-month follow up. These
results continue to support the utility of, and lasting effects of MI when implemented within
an alcohol using population. Further, findings supported the relationship between
confrontational approaches and patient drinking at the 12-month follow up. This study, and
the previous ones, are good examples of the existing research conducted with MI, and
supports the efficacy of MI with alcohol using populations.
In a relatively small (N=23) pilot study conducted by Martino et al. (2000), with
individuals diagnosed with drug dependence and concurrent mood or psychotic disorders,
participants were randomized to receive either a standard intake or a 45-60 minute
motivational interview at intake. Although no significant differences in substance use were
observed, the MI group demonstrated higher rates of attendance through 3 month follow-up.
These findings support the efficacy of MI at improving treatment engagement.
A multisite randomized clinical trial conducted by The Marijuana Treatment Project
Research Group (2004), compared a two session MET intervention with a nine-session multicomponent intervention and a delayed treatment control group. Results indicated that both
the two-session MET and nine-session multi-component interventions were significantly
more effective than the control. While the longer multi-component intervention showed the
greatest decreases in marijuana use, statistically significant reductions in frequency of
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marijuana use and dependence symptoms were also observed for the briefer, two session
MET condition when compared to the control. Similarly, in their brief study of opiate users
attending a methadone maintenance program, Suanders and colleagues (1995), found that
participants randomized to brief MI intervention (N=57) reported significantly greater
increases in commitment to abstinence, fewer opiate related problems, better compliance
with methadone program and longer abstinence rates than those randomized to an
educational control (n-65). Moreover, considerably higher attrition rates at 6-month follow
up were noted for the educational group (49%) as compared to the MI group (30%). Less
favorable results were achieved for increasing or maintaining self-efficacy in the MI
condition, though this may be due to lack of follow through on treatment interventions for
individuals that were seeking additional treatment services.
A number of meta-analyses have done an exceptional job of looking at the MI
literature. One such analysis was conducted by Burke, Arkowitz and Menchola (2003),
reviewed 30 studies that had utilized adaptations of motivational interviewing (AMI).
Results found greater reductions in problem behaviors in AMI’s when compared to notreatment or placebo controls, there was a significant reduction in problem behaviors, but
when compared to previously established effective treatments there was no difference. In the
15 studies that were specific to alcohol and drugs, there was a significant effect when
compared to no treatment or placebo groups, but not when compared to other active
treatments. However, AMI’s were, on average, 180 minutes shorter than traditional active
treatments and resulted in the same effect. This suggests that AMI’s are as effective as other
treatments, and because they can be conducted in a shorter time period, may be more
palatable for implementation. Variability in the effectiveness of AMI’s across problem
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behaviors was also noted, with medium effects observed for drug addiction (0.56) and diet
and exercise (0.56), and small to medium (0.23 to 0.53) effects for alcohol.). Treatment
effects appeared to have consistent durability at follow up.
In their meta analysis of 119 studies targeting outcomes of substance use (tobacco,
alcohol, drugs, and marijuana), health-related behaviors (diet, exercise, safe sex), gambling,
and engagement in treatment, Lundahl, Kunz, Brownell, Tollefson and Burke, (2010) found
consistently small but significant positive effects of MI across a wide range of substances.
The majority of studies reviewed in the analysis related to substance use, which is not
surprising given the origination of MI, however significant results were not limited to this
field, and positive results were observed across all identified areas. Motivational
Interviewing was supported as more effective than non-specific treatments, and, while not
necessarily better than CAU, in some cases it was at least as good. Effects of MI were
observed to be durable up to two years post intervention, and beyond in some cases.
Although the research on the effectiveness of MI/MET among legally mandated
participants is limited, findings that do exist, are encouraging. One existing study is a pilot
conducted by Lincourt et al. (2002), which looked at mandated clients for a 6 session group
based MI grounded intervention. The researchers were concerned that clients were not
benefiting from CAU, had a high level of resistance and were prematurely ending treatment.
Looking specifically at a group of clients who were unable to identify a problem upon
entering treatment (n=167), participants were assigned to receive either MI plus standard
treatment (n=75) or standard treatment only (n=92). Though not randomized, the groups
were equivalent on age, sex, years of education, proportion of those married, and ethnic
makeup. Participants in the MI group were significantly more likely to complete treatment
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than those taking part in standard care alone. Within the MI group, self-report of motivation
significantly increased from baseline to follow-up, and treatment participation and
completion rates were nearly double that of the standard care group. Overall, it was
suggested that motivationally based interventions, especially group, may be beneficial for a
mandated client population.
Harper & Hardy (2000), examined the effectiveness of utilizing MI with clients in a
probation setting, and found that while there was improvement noted across all conditions,
those in contact with probation officers trained in MI techniques exhibited statistically
greater improvements across all conditions. Stevens et al. (2006), looked at a European
sample of Quasi-Compulsory Treatment (QCT) participants and found that in the face of this
research, it has been suggested that people who are coerced into treatment will not be
motivated to change (Cahill, Adinoff, Hosig, Muller & Pulliam, 2003) and thus less likely to
engage and succeed in treatment (DiClemente, Belluno & Nevins, 1999). Despite these
concerns there exists a promising, if limited, research in support of utilizing motivational
treatments among legally mandated clients.
The above findings support the efficacy of MI within a variety of populations across a
range of settings. Additionally, the results are supported as durable and at least as good as
existing treatments. An additional strength of MI is its effectiveness as a standalone BI.
Swanson, Pantalon, & Cohen (1999), and Martino et al. (2000), reported that a single session
of motivational interviewing was associated with better treatment compliance and retention
for dual-diagnosis participants compared with treatment as usual in inpatient and day
treatment settings, respectively. A multisite trial of 450 marijuana-dependent participants
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found that two sessions of MET was significantly more effective than a delayed-treatment
control condition in reducing marijuana use and related outcomes (Babor, 2004).
An additional strength of MI is its use as an adjunct for facilitating engagement and
retention in more traditional drug treatment programs (Saunders, Wilkinson, & Phillips,
1995; Aubrey, 1998; Lincourt, Kuettel, & Bombardier, 2002; Krupski, Sears, Joesch, Estee,
He, Dunn, Huber, Roy-Byrne, Ries, 2010). MI also appears to be differentially effective
with clients who are more angry and resistant, or less ready for change (Project MATCH
Research Group 1997). This is consistent with the original intent and theoretical rationale for
MI. A study conducted in a community treatment program found that a single session of
MET, delivered by staff members who received only brief (single day) training, doubled the
rate of treatment initiation compared to the standard evaluation among drug-abusing parents
referred to treatment through the child protection system (Carroll, Libby, & Sheehan, 2001).
Saunders et al. (1995) reported that a single session of motivational interviewing for
participants entering a methadone maintenance program resulted in clients’ greater
commitment to abstinence and fewer opioid-related problems over a 6-month follow up
period.
While there is much research in support of the efficacy of MI as a treatment strategy,
considerable variability exists with regard to implementation in implementation, longevity
and training. There is still room for improvement in our understanding of what makes MI
work and with whom, and a greater understanding of these questions will allow for the
optimal implementation of this effective intervention. In Project MATCH, the relative
efficacy of an MI-based intervention varied significantly across sites and therapists despite
extensive efforts to standardize training and treatment procedures (Project MATCH Research
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Group 1998). Thus, it appears that variation in the delivery of MI can have substantial impact
on its outcome.
Statement of Problem and Hypotheses
A wide range of studies have examined the efficacy of MI and MET in a range of
settings with an array of target populations (Bien et al., 1993; Steinberg et al, 2002; Stotts et
al. 2001; Carroll et al., 2001; Martino et al., 2000; Martin et al. 2006; Winhusen, Kropp,
Babcock, Hague, Erickson, Renz, et al. 2008). Despite numerous articles in support of
utilizing MI, little research has focused on the variations in the efficacy of MI in different
treatment populations. While MI has demonstrated success with a range of problem areas
(i.e. substance abuse, smoking cessation, gambling, etc.), and across broad population groups
(i.e. adults, adolescents, pregnant women, etc.), less is known about MI’s success within such
broad subgroups.
There is a significant controversy in the general population, criminal justice
community and treatment communities on how best to engage individuals who are legally
motivated to participate in treatment. This controversy will not be resolved without further
research. To date, little research has been devoted to the role of MI in engaging individuals
are legally motivated to treatment. A legal mandate for treatment, depending on the
individual, represents a variable degree of encouragement to attend, participate and make
changes in behaviors. Motivational interviewing by its very nature and design may be an
ideal way to engage and work with legally mandated individuals. Given the frequency of
legal involvement among individuals suffering from substance abuse and dependence this
gap represents a significant limitation in the existing research.
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The few studies that have examined this potentially significant variation in substance
using populations have yielded mixed results. For example, Project MATCH found limited
statistically significant outcomes for treatment matching, while Lincourt, Kuettel and
Bombardier (2002), observed increased attendance and completion among court ordered
participants in a MI group program. Unfortunately these studies also differ
methodologically in ways that make comparisons across studies difficult. At this time there
is a need for further research to help unravel the inconsistency and shed new light on the
subject of MI and it’s applications with legally mandated individuals.
The current study used data collected from a multi-site study of MET with diverse
patient groups and had two specific aims. First, using legal status as an indicator of
motivation (legally incentivized vs. non-legally incentivized) to attend treatment, those with
and without legal incentive were compared on distinct variables (e.g. demographics, primary
substance, etc.). Second, using legal incentive status we compared outcome variables of
treatment retention and substance use frequency (at weekly time points).
Data Checking. Treatment effects will be observed for both treatment groups (MET
and TAU). A reduction in primary substance use during the experimental phase of treatment
will be observer for both treatment conditions. A mixed linear model will be conducted to
examine the effectiveness of the interventions (MET vs. TAU) through experimental
treatment completion (Baseline through Week 4) and the effectiveness of the interventions
(MET vs. TAU) at post intervention follow-up (Week 4 through week 16).
Hypothesis 1. When participants randomized to either MET or TAU are further
subdivided into those with and without legal incentives to enter substance abuse treatment, it
is hypothesized that those in the MET with legal incentives group will have the most positive
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treatment outcomes (greater reduction in days per week of primary substance use; higher
rates of treatment retention at 16 weeks) over time relative to the other three participant
subgroups. Analyses will be conducted to assess the effects of Treatment Group and Legal
Status on two outcome variables, primary substance use (baseline through 16 weekly data
points) and treatment retention (active in treatment at study completion [y,n]).
Hypothesis 2. When participants randomized to either MET or TAU are further
subdivided into those with primary alcohol or primary drug and with and without legal
incentives to enter substance abuse treatment, it is hypothesized that those in the MET
intervention presenting with primary alcohol problems and legal incentives will have the
most positive treatment outcomes over time relative to the other participant subgroups.
Hypothesis 3. When participants randomized to either MET or TAU are further
subdivided into those with high and low motivation to enter substance abuse treatment, it is
hypothesized that those in the MET with low motivation group will have the most positive
treatment outcomes (greater reduction in days per week of primary substance use; higher
rates of treatment retention at 16 weeks) over time relative to the other three participant
subgroups.
Methods
Participants
The present study utilized data from a multi-site randomized clinical trial conducted
under the auspices of the NIDA Clinical Trials Network (CTN). Recruitment occurred at six
community treatment programs and clients providing informed consent were randomized to
receive either motivational enhancement therapy (MET) or treatment as usual (TAU) during
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the first 4 weeks of drug abuse treatment. Substance use and related outcomes were assessed
at baseline as well as 8 and 16 weeks post randomization.
Study Subject. Subjects were (n=461) clients admitted to one of the six participating
community treatment programs who met study inclusion criteria and consented to research
participation. Participants were predominantly male (70.9%); minority (58%); never married
(81.6%); with a mean age of 34.8 (SD=10.2).
Study Sites. For this multi-site protocol, substance abuse treatment programs were
chosen from the network of community providers participating in the NIDA Clinical Trials
Network (CTN). Only outpatient programs were eligible for this particular protocol. To
achieve adequate numbers of study participants, six community treatment programs (CTPs)
were chosen. The final cadre included rural, urban and suburban sites and represented the
States of California, Connecticut and Pennsylvania.
Patient Ascertainment. To maximize sample diversity and representativeness, study
inclusion and exclusion criteria were kept to a minimum. To be included in the study,
individuals had to: 1) be seeking outpatient substance abuse treatment; b) be at least 18 years
of age; and c) meet recent substance use criteria (past month). Excluded were persons found
medically or psychiatrically unstable (could not provide informed consent) or those enrolled
in residential care, methadone maintenance or a medical detoxification only program of care.
Study Procedures
Study recruitment took place over a 37-month period from June, 2001 to July, 2004.
The flow of participants from screening and informed consent through 18-week follow- up
assessment is shown in Figure 3.
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Screened (n = 683)

Met eligibility criteria and provided
informed consent (n = 496)

Completed baseline assessment and
were randomized (n = 461)

TAU (n = 245)

MET (n = 216)

Completed post Intervention
follow up (n = 163)

Completed post intervention
follow up n = 151

Completed follow up 1 (8 weeks post
randomization) (n =156)

Completed follow up 1 (8 weeks post
randomization) (n = 143)

Completed follow up 2(16 weeks post
randomization) (n = 166)

Completed follow up 2 (16 weeks
post randomization) (n=149)

Diagram of eligibility, enrollment, treatment and follow up rates. TAU = treatment as
usual; MET = motivational enhancement therapy
Figure 3. CONSORT Diagram of Eligibility, Enrollment, Treatment and Follow up Rates.
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Screening. Patients seeking admission to one of the six participating outpatient CTPs
learned about the study through posted flyers, their counselors or an on-site Research
Assistant (RA). Those wanting more information (N=683) met with the RA who explained
the purpose of the study and answered any questions they might have. Patients who were
eligible for the study were informed that participation was voluntary and a decision not to
participate would have no negative impact on their treatment at the CTP. Also, they were
told they could discontinue their participation in the study at any time with no negative
consequences to themselves or their substance abuse treatment.
If a person indicated they were not interested in the study, they were referred to their
counselor at the CTP for appropriate care or referral. If instead they wished to be in the
study, the RA proceeded to obtain written informed consent and proceeded with baseline
assessment.
Informed Consent. Potential study participants were told about the study by RAs
who successfully completed all required training, including the training in human subjects
protections, Good Research Practices (GRP), through the Training Subcommittee of the
NIDA CTN. RAs were closely monitored with on-site supervision and corrective action
when necessary. As described above, RAs provided potential subjects with an overview of
the study, then read the consent form aloud, verbatim, stopping to clarify and answer
questions as needed. RAs made sure potential study participants understood their
participation would be voluntary and a decision not to participate would have no negative
consequences on their standard treatment at the CTP. For persons interested in study
participation, the RA witnessed signing of the consent form. The participant was given a
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copy of this form (co-signed and dated by the RA) and the original was stored in a locked file
cabinet separate from the participant’s research data.
The study protocol was reviewed and approved by the Institutional Review Boards
(IRBs) of all participating Universities and their CTP affiliates prior to implementation. In
addition, a Data Safety Monitoring Board (DSMB) was convened by the National Institute on
Drug Abuse (NIDA). The national DSMB monitored study progress and reviewed adverse
events throughout the course of the study.
Baseline Assessment. Baseline assessment required approximately 2 hours to
complete and typically took place on the same day as study recruitment. Assessment
measures included: demographic form, University of Rhode Island Change Assessment
(URICA, Treatment Attitude and Expectations, Substance Dependence Severity Scale
(SDSS), Addiction Severity Index (ASI-‘lite’), Substance Use Calendar (SUC), Short
Inventory of Problems-revised (SIP-R), Treatment Utilization Form (TUF), urine test,
breathalyzer
Random Assignment. Randomization to either the MET or TAU intervention group
occurred following completion of baseline assessment. To balance groups on demographic
and other key variables, URN randomization was used. URN variables included: gender
(male, female), race (Caucasian, African American, Hispanic, Asian, Other), primary drug of
abuse (cocaine, methamphetamine, alcohol, opioids, marijuana, benzodiazepines, other),
mandated to treatment (yes, no), and currently employed (yes, no).
Study Arms. Participants in this study were randomly assigned to ‘treatment
condition’ where they received 3 sessions of either MET or TAU, with the latter defined by
each local CTP.
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TAU Intervention. Participants randomized to the control group received three
sessions of individual counseling as is usually provided at that CTP. Sessions were between
45-55 minutes each and were provided during the four week active phase. Sessions were not
standardized across sites, but were allowed to vary according to standard clinical procedures
of each individual CTP. Clinicians “collected information on substance use and psychosocial
functioning, explained treatment program requirements, discussed the participant’s goals for
treatment, provided early case management and substance use counseling, encouraged
attendance at 12-step meetings, promoted abstinence, and emphasized follow through with
treatment at the clinic” (Ball et al., 2007, p. 559).
MET intervention. Participants randomized to the experimental group received
three sessions of MET from counselors trained by members of CTN staff (Miller & Rollnick,
1991; Miller et al. 1992). Each session was between 45-55 minutes long and the 3 sessions
were scheduled over weeks 1-4 post randomization. First MET therapists reviewed the
participants individualized Personal Feedback Report (PFR). This was created using data
provided during baseline assessment and focused on substance-related problems,
consequences, and reasons for quitting. Second and third sessions then focused upon
discussing plans for changing substance use. Strategies used during MET intervention
included, but were not limited to, asking open ended questions, avoiding and rolling with
resistance, listening with empathy, eliciting self-motivational statements, and reframing.
Therapist Training and Certification. All counseling staff at participating CTPs
were eligible to serve as study therapists. Participation required 1) a willingness to learn a
manualized version of MET, 2) consent to be randomized to provide either MET or TAU,
and 3) be willing to have sessions audio taped. In addition, supervisory staff approval was

34

required. Therapist volunteers were then randomly selected to receive MET training, the
others were asked to continue TAU counseling as before. Fore MET, Training of Trainers
(TOT) model was used, with one individual from each participating Node serving as the local
trainer, supervisor, and intervention fidelity monitor. Node MET trainers were all familiar
with MET prior to attending the two day “training of trainers” workshop where all Node
trainers met to rehearse how staff at their respective CTP’s would be trained in the
intervention. Following this TOT, Node trainers returned to their sites with MET manuals,
training materials (video tapes, role plays, slides), and therapists assigned to MET for the
Node participated in 16 hours of didactic MET training.
Fidelity of the MET intervention provided by therapists was maintained through
regular supervisory meetings, review of audiotapes, and therapist self-monitoring of their
behavior through Therapist Checklists. During the implementation of the study, each CTP
supervisor (or Node MET expert) provided biweekly group supervision (in person or by
phone) and provided individual supervision when it was needed. Supervision included,
reviewing of audiotapes and providing corrective feedback around the use of prescribed
versus proscribed techniques from the MET manual. The on-site MET supervisor received at
least monthly consultation (phone or face-to-face) with the Node MET supervisor regarding
supervisory issues. All sessions in the MET condition were audio taped with a sample rated
by independent evaluators blind to participants’ treatment assignment.
Standard CTP Services. Standard treatment offered at each separate CTP, except
for the 3 individual sessions participants received as part of the study intervention, was not
otherwise constrained or controlled. That is, if it was standard practice at a CTP for patients
to attend weekly group sessions in addition to individual counseling, participants in both
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MET and standard treatment would do so (providing the total number of sessions was equal
across conditions). Participation in treatment after the conclusion of the treatment period was
measured by the Treatment Utilization Form (TUF).
Follow-up Assessments. Follow up Assessment Battery: Follow ups were
conducted with study participant by the RA at the conclusion of the 4 week intervention
period and at 8 and 16 weeks post intervention completion. Follow-up visits took
approximately 1 hour to complete. Data were analyzed using intent-to-treat principles, such
that once a participant was randomized to MET or TAU they were followed and considered
in outcome analyses.
Compensation. Participants were compensated $10 for completing each of the
assessments (pretreatment, each week during treatment, posttreatment, and each of the two
follow-ups. Therefore, participants were eligible to receive a total of $70 if they attended all
seven interviews as scheduled.
Measures
The following assessments were completed at baseline and/or follow ups. All
interviews were conducted by CTN-trained and certified research assistants.
Demographic Form. The demographic form collected information about age,
ethnicity, education level, employment, reason for entering treatment and marital status as
well as information about present substance use.
Addiction Severity Index, Version 5 (ASI, McLellan, Kusher, Metzger, Peters,
Grissom, et al. 1992). The ASI ‘lite’ is a minor variation (six fewer questions and no
interviewer ratings) of the ASI, a widely used instrument that assesses seven domains of
psychosocial functioning commonly effected by alcohol and drug dependence, they are,
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medical, employment/support, alcohol, drugs, legal, family/social, and psychiatric.
Participants provide objective data on the number, extent and duration of problem symptoms
across two time periods: 30 days prior to study enrollment and lifetime (excluding past 30
days).
Treatment Utilization Form (TUF). The 11-item TUF records a number and
duration of substance abuse treatment sessions attended over target periods of assessment
(Carroll et al., 2001). Participant involvement in ancillary services (i.e., non-study related
counseling, child care, medical, psychiatric, vocational, legal and medication services) is
recorded. The TUF was adapted and shortened from the Treatment Services Review (TSR;
McLellan, Alterman, Cacciola, Metzger, & O’Brien, 1992), which has shown to be a reliable
and valid assessment (McLellan et al., 1992).
Substance Use Calendar (SUC). Detailed reports of substance use were obtained
with the SUC, which was the Timeline Followback method (Sobell and Sobell, 1992; Miller
and Dleboca, 1994; Fals-Stewart et. al. 2000). The SUC is administered as a semi-structured
interview. In the present study it focused on the following substances, marijuana, cocaine,
alcohol, methamphetamine, benzodiazepines, opioids, and other drugs). For the present
study, the primary outcome measure was created from the SUC. It was defined as days per
week using the primary substance of abuse. Days of use during each of the 16 weeks of post
enrollment were recorded.
University of Rhode Island Change Assessment (URICA). A 32 item, widely
used, self-report which assesses the participant’s current position regarding readiness for
change (e.g. precontemplation, contemplation, preparation) with regard to substance use
(DiClemente & Hughes, 1990; Callahan, Taylor, Moore, Jungerman, Vilela & Bundy, 2008)
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The URICA when scored, results in 4 composite scores; precontemplation, contemplation,
action, maintenance. A readiness to change score ranging from -2 to 14 is created using the
following formula, contemplation + action + maintenance – precontemplation = Readiness to
Change score. Factor analysis has supported the four-factor structure in some studies (Carney
& Kivlahan, 1995), but not in others (Belding, Iguchi, & Lamb, 1996) and evidence for the
predictive validity of the URICA has produced equally mixed findings (Blanchard et al.,
2003; Henderson, Saules, & Galen, 2004).
Data Management. Data were entered continuously throughout the study by RA’s.
Within one week of data entry the Node data manager reviewed the data entered for missing,
illogical, out of range, and inconsistent values; accuracy of key variables such as gender, age,
race, treatment assignment, and therapist, as well as checks within and across fields for
logical inconsistencies. The above variables were defined in the study Data Dictionary,
which was distributed to Node Data Managers at the outset of the study. Weekly status
reports were distributed to the research assistants which identified any problems that were
encountered that needed correction and clarification.
Participant confidentiality was maintained through a numbered reference system with
participants names appearing only on the “key”, which was kept by the project coordinator at
each site. Additionally, a Federal Certificate of Confidentiality was obtained by each to
ensure that there were no increased risks to participants beyond that which would be incurred
through seeking and entering treatment at the participating CTP.
Variables for Present Study
Variables abstracted from the original data set or created by modifying the original
data set measures are as follows:
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Demographics. Age; race (Caucasian, African American, Hispanic, Other), years of
education, marital status (married/cohabitating, all others [e.g., never married/divorced/
separated/ widowed]), employment status (full time/part time/student,
unemployed/disabled/not working outside the home).
Treatment Condition. Motivational Enhancement Therapy (MET) or Treatment As
Usual (TAU).
Substance Use. Substance use was measured using the Substance Use Calendar
(SUC) at four time points; baseline, post intervention, one month post intervention and three
months post intervention. A single number, representing average number of days using
primary substance, was created from the SUC for mean baseline days of primary substance
use per week. This continuous variable has values from 0-7. Primary substance use during
the study was measured by the SUC and provided 16 sequential weekly data points. These
continuous variables are scored 0-7 and represent the number of days using the primary
substance during each of the 16 weeks post randomization.
Treatment Retention. Treatment retention was measured using the Treatment
Utilization Form (TUF) at the 16 week follow up. It was defined categorically by using the
yes or no response to “participant active in treatment at 16 weeks post-randomization” from
the TUF.
Treatment Phase. The data were divided into two discrete time points, or phases,
because of the possible changes in slope due to the treatment condition. One Phase consisted
of baseline through week 4; the second Phase consisted of week 5 through 16.
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Primary Substance. Initially identified by a categorical variable on the demographic
form; cocaine, methamphetamine, alcohol, opiates, marijuana, other, alcohol and drug). See
percentages on Table 1.
Table 1.
Primary Substance (from Demographic Form) (n = 461)

Cocaine
Methamphetamine
Alcohol
Opiates
Marijuana
Other
Alcohol and Drug

%
23.2%
3.5%
28.6%
9.3%
15.6%
8.2%
11.5%

The initial consideration was to collapse substance use into 3 categories; alcohol only, drug
only, and drug and alcohol. After preliminary analyses it was decided that the frequencies of
these categories were too small for the analyses proposed (see table 2).
Table 2.
Primary Substance Used (3 grouping)

Primary Alcohol
Primary Drug(s)
Primary Alcohol and Drug(s)

%
28.6%
56.4%
15.0%

Several grouping strategies were assessed and the decision was made to collapse the
substance use categories into a dichotomous variable; primary alcohol users and primary
drug users. The primary alcohol variable contains any alcohol use while the primary drug
category contains one or more drugs used but no evidence of primary alcohol use. The
decision to combine the groups was supported by the literature (Ball et al, 2007) and by the
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similarities observed for the alcohol only and alcohol and drug groupings (e.g. age, marital
status, ethnicity, life time # of arrests, lifetime psych # of psych treatments). These
similarities were not observed with the drug only group. The decision was made to combine
the two groups based on sample size of the primary alcohol and drugs group (15%), existing
literature and the similarities between the two groupings. Participants self identified primary
substance was used to create a dichotomous variable with the following values, Alcohol:
participant reported alcohol to be the primary substance they used; or Drug: participant did
not report alcohol as the primary substance use, which then categorized the participant as
primary drug. From this, the two category primary substance variable was created, those
with primary alcohol and those with primary drug (with no alcohol).
Legal status. Using the demographic form, the legal status of the participants
(n=461) was assessed. Participants responded to one of five choices; “mandated or referred
as alternative to jail” (17.4%), “referred by probation/parole officer” (8%), “referred by other
federal/state/private agency” (8.2%), “other legal issues involved” (3.7%), and “no known
legal issues involved” (62.7%). This information was re-coded into a 3 group categorical
variable where 62.7% reported no legal involvement, 20% reported some legal involvement
(“referred by probation/parole officer”; “referred by other federal/state/private agency”;
“other legal issues involved”) and 17.3% reported3 that they were mandated to treatment.
These variables showed that in a three group legal variable that only n=19 cases were
mandated in the primary 'alcohol' group compared to n=61 for 'other drug' group. Some legal
involvement is n=30 for 'alcohol' and n=62 for 'other drug'. No legal involvement is n=152
for 'alcohol' and n=137 for 'other drug'. The small numbers of participants in the mandated to
treatment category for alcohol use (n=19) is small for the research questions and could result
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in complete separation or quasicomplete separation when more complex statistical analyses
with covariates are run. Because of this, it was decided that a dichotomous legal variable
would be used where there would be “any legal involvement” and “no legal involvement”.
This variable was obtained by collapsing the legal status variable from the demographic
form. The “any legal involvement” group was made by collapsing “mandated or referred as
alternative to jail”, “referred by probation/parole officer”, “referred by other
federal/state/private agency”, and “other legal issues involved”. The “no legal involvement”
group was made up of the “no known legal issues involved” category.
Motivation. Motivation was measured using a composite score created from the
University of Rhode Island Change Assessment (URICA). The URICA is a 32 question
measure of motivation. The URICA when scored, results in 4 composite scores;
precontemplation, contemplation, action, maintenance. A readiness to change score is
created using the following formula, contemplation + action + maintenance –
precontemplation = Readiness to Change Score. The Readiness to Change score can range
from -2 to 14. There are no agreed up on cut off scores presented in the literature. While
several potential algorithms are presented in the literature (Callaghan, Taylor, Moore,
Jungerman, Andrioni De Biaze Vilela, Budney, 2008) there is no consensus. As such, a
mean separation was done to create a low and high motivation category using this sample.
One algorithm, created by the Addition Technology Transfer Center (ATCC) suggested cut
off scores for the three stages of change; precontemplation (-2-10.15), contemplation (10.1611.80), action/maintenance (11.81 and above). The mean separation yielded comparable
results to the ATCC algorithm. Using the mean separation, a total of 225 participants were
categorized as low motivation, while 226 were categorized as high motivation. Using the
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ATCC algorithm 226 participants were precontemplation and 225 were either contemplation
or action / maintenance. Using this procedure, motivation was dichotomized into: Low
Motivation, those with a Readiness to Change score below -2-10.14; and High Motivation,
those with Readiness to Change scores 10.15-14.
Data Analysis Plan
Demographics and Initial Analyses. Statistical analyses were performed using
SPSS v.18.0 (SPSS, Chicago, IL). The data set obtained for this secondary data analysis had
already been prepared for use (see Ball et al., 2007). Comparisons of participant
characteristics between MET and TAU were performed by means of ANOVA and chi-square
analysis. ANOVA and chi-square analysis were also conducted to examine differences in
site characteristics. Descriptive analyses to describe demographic characteristics (e.g., age,
race) were calculated.
Hypotheses. The hypothesized relationships between intervention group and legal
status on primary substance use and treatment retention were examined (Hypothesis 1). A
mixed linear model was fit with Treatment Group, Legal Status, Time, all possible
interactions and the treatment outcome (dependent measure) of Substance Use was
examined. Nonsignificant interactions and main effects, and additional covariates, that did
not add to the model were removed until the most parsimonious model was arrived at.
Binary logistic regression was conducted to predict the outcome of treatment retention
(defined categorically by “participant active in treatment at 16 weeks post-randomization”,
yes/no) using Treatment Group (MET, TAU) and Legal Status (incentives or no incentives)
as predictors (Hypothesis1).
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A relationship was hypothesized for intervention group and primary substance and
legal status on primary substance use was examined (Hypothesis 2). A mixed linear model
was fit with Treatment Group, Primary Substance, Legal Status, Time, all possible
interactions and the treatment outcome (dependent measure) of Substance Use was
examined. Nonsignificant interactions and main effects that did not add to the model were
removed until the most parsimonious model was achieved.
The hypothesized relationships between intervention group and motivation on
primary substance use and treatment retention were examined (Hypothesis 3). A mixed linear
model was fit with Treatment Group, Motivation, Time, all possible interactions and the
treatment outcome (dependent measure) of Substance Use was examined. Nonsignificant
interactions and main effects that did not add to the model, including additional covariates,
were removed until the most parsimonious model was arrived at. Binary logistic regression
was conducted to predict the outcome of treatment retention using Treatment Group and
Motivation (high/low) as predictors (Hypothesis 3).
Results
Data Analysis
Outliers and Tests of Normality. Frequency distributions of continuous variables
that represented substance use were examined for evidence of non-normality and outliers. If
the data contained outliers and there was a meaningful rationale to remove them (e.g.,
outliers were not expected), they were coded as missing. If by removing outliers the data
were normal, no further changes were made to the variable. Variables were re-coded from
continuous to categorical variables because non-normal variables prevented the use of
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ANOVA. Following the re-coding of any non-normal variables, mean scores and frequencies
were calculated for each variable.
Initial examination of years of education completed was found to be skewed and
kurtotic. When one outlier was removed however, the data were normally distributed,
remaining slightly Kurtotic but below 1.5, with average education being 12.55 years (SD=2).
The lifetime arrests of participants was non-normally distributed. A total of 11 were over 3
SD above the mean and were removed. After the removal of the 11 extreme data points the
descriptive statistics were re-run and while the sample was still slightly skewed and kurtotic,
the values were not above 1.5 on either statistic. Several of the variables were assessed only
at baseline and as such, contain the whole (n = 461) sample. These variables include gender,
ethnicity, age, employment patter, primary substance used and marital status. No values
were missing from these variables. These variables were normally distributed and within
expected ranges.
Substance use was assessed at 4 time points. From this, a baseline use mean score
was created and 16 weekly time points. Weekly data points were created from the SUC
based on the responses at the 4 time points. A total of 425 participants provided baseline
substance use. Participant attrition was expected as treatment progressed. Missing data were
coded as such.
Demographics: Descriptive statistics for the study participants (N=461) are
summarized in Table 3. Age was normally distributed with the average age of participants
being 34.8 years (SD= 10.21, 18-64 years old). The sample was male (70.9%). Race was
evenly distributed between Blacks (42%) and Caucasian (42%), with the remaining 11%
Hispanic and 5% “Other”. Participants reported a mean of 12.5 years formal education (SD

45

= 2.00, range 7-20 years) and most were never married or single (81.6%) at the time of study
participation.
Table 3.
Participant Characteristics: MET (n = 216) and TAU (n =245)

Legal Status
No legal involvement
Legal involvement
Primary Substance
Alcohol
Drug(s)
Age (years)
Gender
Male
Female
Education (years)
Marital Status
Married/cohabitating
Single/divorced/separated/widowed
Ethnicity
Caucasian
African American
Hispanic
Other
Currently awaiting charges or
sentencing (y)
Employed in the past 30 days (y)
Total lifetime number of arrests
Total number of months incarcerated
lifetime

MET
% or M (SD)

TAU
% or M (SD)

Total Sample
% or M (SD)

63.4%
36.6%

62.0%
38.0%

62.7%
37.3%

45.4%
56.6%
33.0 (10.5)

42.0%
58.0%
35.5 (9.9)

43.6%
56.4%
34.8 (10.2)

69.9%
30.1%
12.6 (2.0)

71.8%
28.2%
12.5 (2.0)

70.9%
29.1%
12.6 (2.0)

20.4%
79.6%

16.7%
83.3%

18.4%
81.6%

45.4%
39.4%
10.2%
5.1%
13.5%

38.8%
44.9%
11.0%
5.0%
16.3%

41.9%
42.1%
10.6%
5.4%
15%

40.3%
4.8(5.2)
10.4(22.3)

38.8%
5.2(5.5)
10.0(21.3)

39.5%
5.0 (5.4)
10.2(21.7)

Primary Substance Use Characteristics. Chi-square tests of the relationship
between categorical demographic variables and substance use and standard crosstabs were
used for comparison of continuous variables (see Table 5). Men and women did not differ in
patterns of substance use characteristics, χ2 (2,461) = .848, p > .05. However, a difference
was found across race/ethnicity groups specifically, between substance used (primary
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alcohol, primary drug) and identified ethnicity χ2 (3, 461) = 13.21, p < .004, Cramer’s V =
.17. Caucasian and African Americans were similar, with between 41% and 51% reporting
primary alcohol use, where as Hispanics and ‘other’ reported only 24.5% and 36% primary
alcohol use respectively. Substance use also varied by marital status χ2 (5, 461) = 22.15, p <
.001, Cramer’s V = .22. For alcohol as the primary substance, the percentage of participants
who were married was 22.9% compared with only 10% of other drug users and 48.3% of
alcohol users were never married compared with 66.5% of other drug users. A one-way
between groups analysis of variance showed a significant difference between primary
substance used and years of education, F(1,458) = 17.264, p <.001. Additionally there was a
significant difference between substance and age F (1,459) = 45.506, p <.001. A difference
was found across current employment χ2 (1, 461) = 7.39, p = .007, Cramer’s V = .131. Of
the participants who primarily used alcohol, 46.8% had full or part time employment
compared with 33.8% of primary drug users. Rates of various substance use characteristics
are further summarized in Table 4.
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Table 4.
Primary Substance Use Characteristics: Primary Alcohol (n = 201) and Primary Drug (no
alcohol) (n = 260)
Primary
Alcohol
% or M
(SD)
Age (years)
Gender
Male
Female
Education (years)
Marital Status
Married/cohabitating
Single/divorced/separated/widowed
Ethnicity
Caucasian
African American
Hispanic
Other
Employment
Full or part time past 30 days
Unemployed/disability/not working

Total
Sample
% or M
(SD)

38.3 (9.9)

Primary
Drug (no
alcohol)
% or M
(SD)
32.1 (9.6)

p

71.6%
28.4%
13.0 (2.1)

70.4%
29.6%
12.2 (1.9)

70.9%
29.1%
12.6 (2.0)

ns
<.001***

24.9%
75.1%

13.5%
86.5%

18.4%
81.6%

.002**

39.8%
49.8%
6.0%
4.5%

43.5%
36.2%
14.2%
6.2%

41.9%
42.1%
10.6%
5.4%

.004**

46.8%
53.2%

33.8%
66.2%

39.5%
60.5%

.005**

34.8 (10.2) <.001***

Note. *p <.05. **p <.01, ***p<.001
Legal Status. As anticipated, a chi-square test for independence did show a
significant association between legal status from the demographic form (mandated or
referred as alternative to jail, referred by probation/parole officer, referred by other
federal/state/private agency, other legal issues involved, and no known legal issues involved)
and a dichotomous (yes/no) variable from the ASI which asked “was the treatment
admission prompted by the legal system” χ2(4,n=460) = 393.15, p < .001, Cramer’s V = .92.
A second Chi-square test for independence showed a significant association between legal
status as a 3 category variable (legally mandated, some legal involvement, no legal
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involvement) and the dichotomous (yes/no) variable from the ASI which asked “was the
treatment admission prompted by the legal system” χ2(2,n=460) = 372.00, p < .001,
Cramer’s V = .90. A Chi-square test for independence (with continuity correction) showed a
significant association between dichotomous legal status created from the demographic form
(any legal involvement/no known legal involvement) and a dichotomous (yes/no) variable
from the ASI which asked “was the treatment admission prompted by the legal system”
χ2(1,n=460) = 353.63, p < .001, Cramer’s V = .88. A Pearson product-moment correlation
coefficient conducted with these two variables shows a strong positive correlation, r = .918,
n=461, p < .001, with 84% shared variance. These results suggest that the use of the
dichotomous legal variable created from the legal status question on the demographic form is
significantly correlated with the legal status variable from the ASI and encourages the use of
only one of the legal variables identified in this protocol. The collapsed variable used was
the dichotomous variable created from the Demographic Form.
There was a significant association observed between the dichotomous legal status
and primary substance used. A Chi-square test of independence (with continuity correction)
showed χ2 (1, 460) = 24.51, p < .001, Cramer’s V = .24. Almost three quarters (71.5%) of
those participants who had legal involvement identified drugs as their primary substance
compared with only one quarter (28.5%) of participants who identified alcohol as their
primary substance.
A Chi-square test of the relationship between categorical demographic variables and
legal status and standard crosstabs were used for comparison of continuous variables (see
Table 5). A one-way between groups analysis of variance showed a significant difference
between legal status and years of education, F (1,458) = 10.60, p =.001. Additionally there
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was a significant difference between legal status and age F (1,459) = 77.43, p <.001.
Participants with legal involvement were significantly younger (M = 29.77, SD = 9.15) than
those entering treatment without legal involvement (M = 37.79, SD = 9.64). A difference
was also observed across current employment χ2 (1,461) = 4.36, p = .019, Cramer’s V =
.029. Of those who were legally involved, 45.9% had full or part time employment
compared with 54.1% who did not. For participants with no legal involvement 35.6% held
full or part time employment compared with 64.4% who did not.
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Table 5.
Participant Legal Characteristics: No Legal Involvement (n =288) and Legal Involvement (n
= 172)
Legal
Involvement
% or M
(SD)

No Legal
Involvement
% or M
(SD)

Total
Sample
% or M
(SD)

Primary Substance Used
Primary Alcohol
Primary Drug(s)
Age (years)

28.5
71.5
29.77 (9.15)

52.6
47.4
37.79 (9.64)

43.6
56.4
34.80
(10.21)

<.001***
<.001***

Gender
Male
Female
Education (years)

73.8
26.2
12.20 (1.89)

69.2
30.8
12.78 (2.00)

70.9
29.1
12.55
(2.00)

Ns
.001**

12.8
87.2

21.8
78.2

18.4
81.6

.016*

46.5
34.3
12.8
6.4

39.1
46.7
9.3
4.8

41.9
42.1
10.6
5.4

Ns

45.9
54.1

35.6
64.4

39.5
60.5

.019*

Marital Status
Married/cohabitating
Single/divorced/separated/widowed
Ethnicity
Caucasian
African American
Hispanic
Other
Employment
Full or part time past 30 days
Unemployed/disability/not working

Note. *p <.05. **p <.01, ***p<.001
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p

Readiness to Change. The URICA Readiness to Change score was computed for 452
of the participants. A total of 9 participants had incomplete URICA subscales which did not
allow for the creation of a Readiness to Change score for these participants and they were
excluded listwise from analyses using the Readiness to Change score. An independent
samples t-test was conducted to compare the Readiness to Change (high, low) scores at
baseline for the two treatment conditions (MET, TAU). There were no significant difference
in scores for MET (M=10.07, SD = 2.01) and TAU (M=10.34, SD=1.80); t (450) = 1.51,
p=.132. This shows that there is not a significant difference between the two treatment
conditions and the Readiness to Change score at the baseline assessment.
A Chi-square test of independence for Readiness to Change (high, low) and intervention
assignment (MET, TAU) did not show a significant difference χ2 (1, 451) = 3.37, p = .066.
Additionally, an analysis of primary substance used did not result in a significant difference,
χ2 (1, 451) = .660, p = .417. A significant difference was observed for legal status and
Readiness to Change score, χ2 (1, 451) = 48.322, p < .001, Cramer’s V = .332. Participants
who did not have legal involvement were more likely to have high motivation (62.9%) while
participants who were legally involved were more likely to have low motivation (71.4%).
There was also a significant difference present for gender and Readiness to Change score, χ2
(1, 451) = 10.818, p = .001, Cramer’s V = .160. Within gender, men were more likely to be
in low motivation (55%) compared to women (37.4%). There was also a significant
difference for age, F (1,459) = 37.51, p <.001, with participants in the high motivation group
being older. Further explanation of findings can be seen in Table 6.
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Table 6.
Primary Characteristics of Readiness to Change Categories: Low (n =226), High (n = 226)

Treatment Condition
MET
TAU
Primary Substance Used
Primary Alcohol
Primary Drug(s)
Legal Status
Legal involvement
No legal involvement
Age (years)
Gender
Male
Female
Education (years)
Ethnicity
Caucasian
African American
Hispanic
Other

Low
Motivation
% or M (SD)

High
Motivation
% or M
(SD)

p

54.7%
45.6%

45.3%
54.4%

ns

47.5%
51.8%

52.5%
48.2%

ns

71.4%
37.1%
32.0(10.3)

28.6%
62.9%
37.7(9.3)

<.001***
<.000***

78.2%
21.8%
12.4(1.8)

63.7%
36.3%
12.7(2.2)

.001**
ns

52.3%
47.9%
50.0%
100.0%

47.7%
52.1%
50.0%
0%

ns

Note. *p <.05. **p <.01, ***p<.001
Replication Analyses. The first aim of this study was to replicate the findings from
the primary article which utilized this data set. To assure the data set was the same and to
provide sample characteristics the results of the primary retention and substance use
outcomes by therapy condition and program site were replicated and are presented in table 7.
The results of the replication of patient and program differences across site are presented in
table 8. There were no substantive differences between the results of these analyses and
those previously conducted by the primary article (Ball et al., 2007). Some fluctuations were
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observed, however, the fluctuations were minor and likely due to differences in the statistical
packages used.
Table 7.
Patient and Program Differences across Site (n = 461)

Gender (female)
Ethnicity
African Amer.
Caucasian
Hispanic
Other
Age
Years education

Site 1
% or M
(SD)
17.0

Site 2
% or M
(SD)
26.0

Site 3
% or M
(SD)
25.0

Site 4
% or M
(SD)
29.5

Site 5
% or M
(SD)
48.0

Total
% or M
(SD)
29.1

25.0
59.0
13.0
3.0
35.33
(9.7)
11.84
(2.0)

31.0
63.0
1.0
5.0
39.56
(9.5)
13.07
(2.0)

45.0
40.0
14.0
1.0
29.35
(9.4)
12.14
(1.7)

45.9
42.6
3.3
8.2
34.47
(11.4)
12.36
(1.6)

64.0
6.0
19.0
11.0
35.15
(9.1)
13.42
(2.6)

41.9
42.1
10.6
5.4
34.80
(10.2)
12.58
(2.1)

<.005
<.005

<.005
<.005
<.005**

Marital status
Married/cohabitat
ing
Widowed/
separated
Not married/
single
Previous
Treatment
Alcohol
Drug
# Psychiatric
Treatment
Legal involved
Court mandate
Legal sys referral
Current probation
/parole
# lifetime arrests

p

6.0

34.0

9.0

6.6

32.0

18.4

32.0

27.0

12.0

23.0

21.0

23.0

62.0

39.0

79.0

70.5

47.0

58.6

56.6
41.0
20.0
84.8
45.0
53.0
1.95 (3.1) 1.01 (1.6) .77 (2.2)

41.0
42.6
5.31
(9.8)

39.0
57.0
2.20
(2.7)

39.3
57.6
1.99
(4.5)

<.005**
<.005**

12.0
13.1
27.3

57.0
75.0
68.0

55.7
54.1
39.3

18.0
23.0
28.0

28.2
32.2
33.9

<.005**
<.005**
<.005**

6.89 (7.5) 2.61 (3.7) 5.48
(7.0)

7.62
(8.7)

7.18
(8.2)

5.81
(7.3)

<.005**

9.0
4.0
9.0
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Table 7 (continued)
# months
incarcerated
Primary
substance
Alcohol
Cocaine
opioids
marijuana
Years substance
Use
Alcohol
Cocaine
Opioid
Marijuana

17.11
(26.9)

2.08 (8.4) 10.31
(12.8)

12.61
(23.0)

9.88
(23.5)

10.20
(21.7)

<.005**

9.23 (7.2) 10.36
12.07
(9.1)
(10.7)
6.92 (7.2) 9.38 (8.8) 5.32
(8.5)
6.90 (7.5) 4.17 (7.1) 2.89
(6.6)
2.30 (5.2) .25 (1.8) 1.22
(4.5)
3.57 (6.4) 3.10 (7.2) 7.08
(10.1)
13.21
15.22
9.74
(9.8)
(10.4)
(9.3)
8.06 (7.0) 6.25 (7.4) 3.76
(6.3)
1.32 (2.8) 0.10 (0.8) 0.80
(2.2)
9.27 (9.0) 8.18 (8.6) 7.51
(7.4)

7.47
(9.0)
7.08
(8.5)
2.54
(5.3)
0.13
(0.5)
1.95
(4.1)
15.70
(10.6)
6.44
(8.4)
1.77
(5.3)
8.03
(7.3)

11.58
(8.9)
7.55
(8.3)
3.95
(6.7)
1.03
(3.9)
4.26
(8.8)
9.60
(8.4)
4.01
(5.3)
1.03
(3.8)
6.06
(7.6)

10.44
(9.2)
7.26
(8.2)
4.22
(6.9)
1.06
(3.8)
4.16
(8.0)
12.44
(10.0)
5.64
(7.0)
0.94
(3.1)
7.79
(8.1)

<.005**

Note. *p <.05. **p <.01, ***p<.001
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<.005**
<.005**
<.005**
<.005**
<.005**
<.005**
<.005**
.079

Table 8.
Outcome by Site and Therapy Condition (n = 461)

Days enrolled
in Tx Site 1
Days enrolled
in Tx Site 2
Days enrolled
in Tx Site 3
Days enrolled
in Tx Site 4
Days enrolled
in Tx Site 5
Days enrolled
in TX
Total
% enrolled at
follow up
Site 1
% enrolled at
follow up
Site 2
% enrolled at
follow up
Site 3
% enrolled at
follow up
Site 4
% enrolled at
follow up
Site 5
% enrolled at
follow up
Total

MET
M (SD)
71.33 (42.97)

TAU
M (SD)
74.61 (40.90)

65.83 (38.91)

60.55 (30.36)

87.09 (44.97)

96.57 (38.35)

74.63 (38.09)

63.34 (44.11)

58.92 (44.70)

52.88 (42.89)

72.23 (43.14)

69.23 (42.12)

.33 (.48)

.41 (.50)

.28 (46)

.19 (.40)

.74 (.44)

.85 (.35)

.43 (.50)

.41 (.50)

.43 (.50)

.43 (.50)

.47 (.50)

.46 (.50)

Note. *p <.05, **p <.01, ***p<.001
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Therapy
Condition

Program Site

Therapy X
Site

F (1.376) =
F (4.376) =
.217, P=.642 9.556, P
<.001***

F (4.376) =
.781, P =
.583

F (1.375) =
F (4.375) =
.108, P=.743 .16.92,
P<.001***

F (4.375) =
.606,
P=.659

Data Checking
The first aim on the current study was to replicate findings reported by Ball et al.
(2007) in the primary outcome paper. Previous research showed that with this sample there
would be a reduction in primary substance use during the experimental phase of treatment
which would be observed for both intervention conditions (MET, TAU). A mixed linear
model tested the effectiveness of the interventions (MET vs. TAU) by substance use through
intervention completion (Baseline through Week 4) and the effectiveness of the interventions
(MET vs. TAU) post-intervention (Week 4 through week 16).
A Mixed Linear Model was run with the following variables; Treatment Group
(MET, TAU), Phase (baseline through week 4, week 5 through week 16), and Time (baseline
followed by 16 weekly data points). Each participants unique identification number was
used to anchor their data. The study involved an intervention arm (MET or TAU for week 14) and substance abuse treatment at participating programs throughout the 16 week period of
assessment. Since the first 4 weeks provided a different level of care from that offered in
weeks 5-16, it was deemed inappropriate to force a single linear estimate through all 17 data
points (baseline and 16 weeks thereafter). Specifically the original study posited that
changes in slope should accompany the transition between the intervention treatment phase
and post intervention. Instead, a repeated covariance type of compound symmetry was
chosen thereby allowing for the split-plot design, necessary for the Phase variable.
The model using Treatment Group, Phase, and Time was run with all possible two, and threeway interactions; results are summarized in Table 9.
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Table 9.
Data Checking: Treatment Group X Phase X Time

Model 1 (without additional covariates)
Variable
Phase
Time
Treatment Group
Phase X Time
Phase X Treatment Group
Time X Treatment Group
Phase X Time X
Treatment Group

F
165.442
228.595
1.097
231.590
9.584
6.329
8.333

P
.000***
.000***
.295
.000***
.002*
.012*
.004**

Note. *p <.05, **p <.01, ***p<.001
As reported by Ball et al. (2007) the present analyses found a significant main effect
for Phase, F (1,5170.002) = 165.442, p < .001, and Time, F (1,5242.150) = 228.595, p <
.001. Significant two-way interactions were observed for Treatment Group X Phase, F
(1,5149.870) = 9.584, p = .002, Treatment Group X Time, F (1,5210.135) = 6.329, p = .012,
and Phase X Time, F (1,5227.472) = 231.590, p < .001.
The present study also replicated the significant three way interaction (see Figure 4)
found in Ball et al. (2007) between Treatment Group X Phase X Time, F(1, 5197.615) =
8.333, p = .004. As shown in Figure 4, participants randomized to either MET and TAU
interventions significantly reduced their substance use during the 4-week intervention phase.
However, participants in the MET intervention maintained these improvements over the
subsequent 12 week post intervention period, while TAU participants showed an increase in
substance use during the post intervention period.
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Week = baseline through 16 weeks; Days per week substance use = days per use of primary
substance during week each week that was assessed; MET = motivational enhancement
therapy; TAU = treatment as usual.
Figure 4. Data Checking: Three Way Interaction for Treatment Group X Phase X Time
Hypothesis One
To test Hypothesis 1, a mixed linear model was fit with the following predictor
variables; Treatment Group (MET, TAU), legal status at treatment entry (no legal
involvement, legal involvement) and Time (mean weekly use prior to entry into treatment
and 16 weekly data points). The model tested Treatment Group, Time and Legal Status and
all interactions terms: Treatment Group, Time, Legal Status, Treatment Group X Time,
Treatment Group X Legal Status, Time X Legal Status and Treatment Group X Time X
Legal Status. Eight variables were added to the model as additional covariates. The eight
covariates run were; gender, age, years of education, race (White, Minority), currently
awaiting charges or sentencing (y/n), employed past 30 days (y/n), total number of lifetime
arrests, total lifetime number of months incarcerated. The findings from this model with
these additional variables are presented in Table 10 (Model 1). Then, to see if these
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experimental effects remained significant, the model was rerun without the additional
covariates. None of the additional covariates contributed significantly to model 1 and
therefore, they were not retained. The full model without the additional covariates was
retained and is shown in table 10 (Model 2). The following were found to be nonsignificant
and were removed to create the most parsimonious model, Time X Treatment Group X Legal
Status, F(1,5164.687) = .011, p =.917, Treatment Group X Legal Status F(1,356.439) =
2.253, p = .134, Time X Treatment Group, F(1,5163.010) = .186, p = .667, and Treatment
Group, F(1,356.664) = .061, p = .805.
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Table 10.
Hypothesis 1: Mixed Linear Model With and Without Additional Covariates
Model 1 (with
Model 2 (without
Model 3(final
additional
additional
model)
covariates)
covariates)
Variable

F

p

F

p

Treatment group

.828

.363

1.164

.281

Time

79.837

.000*** 81.860

.000***

143.825 .000***

Legal Status

5.599

.018**

7.887

.005**

6.095

.014*

Treatment Group X Time

.039

.843

.119

.731

Treatment Group X Legal 1.494
Status

.222

2.141

.144

Time X Legal Status

33.470

.000*** 33.871

.000***

61.490

.000***

Treatment Group X Time
X Legal Status

.000

.992

.917

Gender (M/F)

.403

.526

Age

.002

.963

Years of Education

.039

.843

Race (W/M)

.053

.818

Currently waiting
Charges or Sentencing
(Y/N)

.043

.837

Employed Past 30 Days
(Y/N)

.883

.348

Total # of Lifetime
Arrests

1.128

.289

Total # of Months
Incarcerated

.638

.425

Readiness to Change
(mean separated)

.089

.766

.011

Note. *p <.05, **p <.01, ***p<.001
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F

p

The significant main effects for the most parsimonious model (Model 3) included
Time, F(1,5171.655) = 143.825, p < .001, Legal Status F(1,440.844) = 6.095, p = .014, and
as shown in Figure 5, a significant 2 way interaction for Time X Legal Status F(1,5168.642)
= 61.490, p < .001. As seen in Figure 6, participants entering treatment without legal
incentives had similar reductions in substance use regardless of intervention group
assignment (MET or TAU). In contrast, participants in both interventions conditions with no
legal incentives showed little or no reductions in substance use.

Legal = any legal involvement; No Legal = No legal involvement
Figure 5. Hypothesis 1: Two-way Interaction for Time X Legal Status (Model 3)
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MET-L = motivational enhancement therapy with legal involvement; MET-NL =
motivational enhancement therapy with no legal involvement; TAU-L = treatment as usual
with legal involvement; TAU-NL = treatment as usual with no legal involvement.
Figure 6. Hypothesis 1: Days Using Primary Substance per Week Separated by Treatment
Group and Legal Status (Model 2)
A logistic regression was performed to assess the effects of Treatment Group and
Legal Status on treatment retention at study completion. The full model was significant, χ2
(2,461) = 8.242, p = .016, indicating that the model was able to distinguish between
participants who did and did not stay involved in treatment through study completion. As
seen in Table 11, only Legal Status made a significant contribution to the model χ2 (1,461) =
7.889, p = .005. The strongest predictor of remaining in treatment was legal involvement,
recording an odds ratio of 1.873. This indicates that participants with legal incentives are
almost twice to still be in treatment at 16 weeks post-enrollment compared to participants
without such incentives. This finding mirrors previous findings and shows that Treatment
Group was not significant for changing treatment retention, while Legal Status resulted in
significant differences in treatment retention from baseline to treatment completion.
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Table 11.
Logistic Regression Predicting the Likelihood of Being Active in Treatment at Study
Completion

Treatment
Group
Legal
Status
Constant

β

S.E.

Wald χ2

df

p

.019

.207

.009

1

.627

.223

7.889

1

.658

.158

17.326

Lower

Upper

.926

Odds
Ratio
1.019

.680

1.529

.005**

1.873

1.209

2.901

.000

1.931

Note. *p <.05, **p <.01, ***p<.001
Taken together, Hypothesis one was not supported by study findings as participants
with legal involvement, regardless of intervention conditions, generally reported greater
reductions in substance use over the course of treatment than those without legal incentives.
Hypothesis Two
To test Hypothesis Two, a Mixed Linear Model was fit with the following predictor
variables; Treatment Group (MET, TAU), Legal Status at treatment entry (no legal
involvement, legal involvement), Primary Substance (alcohol, drug [no alcohol]) and Time
(mean weekly use prior to entry into treatment and 16 weekly data points). The model was
fit to test Treatment Group, Legal Status, Primary Substance, Time and all interactions terms:
Treatment Group, Primary Substance, Legal Status, Time, Treatment Group X Primary
Substance, Treatment Group X Time, Treatment Group X Legal Status, Primary Substance
X Time, Primary Substance X Legal Status, Time X Legal Status, Treatment Group X
Primary Substance X Time, Treatment Group X Primary Substance X Legal Status,
Treatment Group X Time X Legal Status, Primary Substance X Time X Legal Status and
Treatment Group X Primary Substance X Time X Legal Status.
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None of the additional covariates added to Hypothesis 1 contributed significantly to
this model and therefore, they were not retained. The results of this model are presented in
Table 12.
A significant main effect was seen for Time, F (1,5148.617) = 23.244, p < .001.
Significant two-way interactions were seen for Treatment Group X Time F(1,5130.795) =
5.235, p = .022, and Time X Legal Status, F(1,5140.162) = 11.860, p = .001. Significant
three-way interactions were present for Treatment Group X Primary Substance X Time,
F(1,5145.783) = 6.377, p = .012, and Treatment Group X Time X Legal Status,
F(1,5127.103) = 6.722, p = .010.
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Table 12.
Hypothesis 2: Final Model Retained for Mixed Linear Model of Treatment Group, Primary
Substance, Time, Legal Status and All Interactions
Variable
Treatment Group
Primary Substance
Legal Status
Time
Treatment Group X Primary Substance
Treatment Group X Time
Treatment Group X Legal Status
Primary Substance X Time
Primary Substance X Legal Status
Time X Legal Status
Treatment Group X Primary Substance X Time
Treatment Group X Primary Substance X Legal
Status
Treatment Group X Time X Legal Status
Primary Substance X Time X Legal Status
Treatment Group X Primary Substance X Time X
Legal Status

F
1.108
.263
1.972
23.244
.298
5.235
.986
.109
.079
11.860
6.377
.006

p
.293
.608
.161
.000***
.585
.022*
.321
.741
.779
.001**
.012*
.938

6.722
.010
11.231

.010*
.919
.001**

Note. *p <.05, **p <.01, ***p<.001
In addition, the four way interaction for Treatment Group X Primary Substance X
Time X Legal Status was significant, F(1,5152.083) = 11.231, p = .001 and is shown in
Figure 7. To more clearly describe these results, the three-way interaction for Treatment
Group X Primary Substance X Time is shown for participants with and without legal
incentives in Figures 8 and 9. Entering treatment without legal incentives across both
intervention conditions, shown in Figure 8, resulted in similar slow decreases in substance
use through treatment except for those in the MET condition using drugs. Those individuals
actually showed a slow increase from baseline substance use. In contrast, as shown in Figure
9, participants across both treatment conditions with legal incentives showed a more
pronounced decreases in substance use. The one exception to this pronounced decrease was
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for participants in the MET condition with a primary substance of alcohol, these participants
showed a more modest decrease across treatment comparable to what was seen for
participants without legal incentives.
Taken together, Hypothesis Two was not supported by study findings as participants
with legal involvement and alcohol use in the MET intervention showed only modest
reductions in substance use. Overall, regardless of treatment condition or primary substance
used, those with legal involvement generally reported greater reductions in substance use
over the course of treatment than those without legal incentives.
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MET-A-L = motivational enhancement therapy with alcohol primary and legal involvement;
MET-A-NL = motivational enhancement therapy with alcohol primary and no legal
involvement; MET-D-L = motivational enhancement therapy with drug primary and legal
involvement; MET-D-NL = motivational enhancement therapy with drug primary and no
legal involvement; TAU-A-L = treatment as usual with alcohol primary and legal
involvement; TAU-A-NL = treatment as usual with alcohol primary and no legal
involvement; TAU-D-L = treatment as usual with drug primary and legal involvement; TAUD-NL = treatment as usual with drug primary and no legal involvement .
Figure 7. Hypothesis 2: Four-way Interaction of Treatment Group X Legal Status X
Primary Substance X Time
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MET-A-NL = motivational enhancement therapy with alcohol primary and no legal
involvement; MET-D-NL = motivational enhancement therapy with drug primary and no
legal involvement; TAU-A-NL = treatment as usual with alcohol primary and no legal
involvement; TAU-D-NL = treatment as usual with drug primary and no legal involvement.
Figure 8. Hypothesis 2: Three-way Interaction of Treatment Group X Primary Substance X
Time for Participants Without Legal Involvement
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MET-A-L = motivational enhancement therapy with alcohol primary and legal involvement;
MET-D-L = motivational enhancement therapy with drug primary and legal involvement;
TAU-A-L = treatment as usual with alcohol primary and legal involvement; TAU-D-L =
treatment as usual with drug primary and legal involvement.
Figure 9. Hypothesis 2: Three-way Interaction of Treatment Group X Primary Substance X
Time for Participants With Legal Involvement
Hypothesis Three
To test Hypothesis Three, a Mixed Linear Model was fit with the following predictor
variables; Treatment Group (MET, TAU), Motivation at treatment entry (low, high), and
Time (mean weekly use prior to entry into treatment and 16 weekly data points). The model
was run with Treatment Group, Time, Motivation and all interactions terms: Treatment
Group, Time, Motivation, Treatment Group X Time, Treatment Group X Motivation, Time
X Motivation and Treatment Group X Time X Motivation.
None of the additional covariates added contributed significantly to this model and therefore,
were not retained. The results of this model are presented in Table 13.
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After the removal of nonsignificant terms a significant main effect was seen for Time,
F(1,5153.926) = 86.161, p < .001. A significant three way interaction for was seen for Time
X Treatment Group X Motivation F(1,5330.429) = 5.715, p = .017. As seen in Figure 10, all
participants showed a pattern of reducing substance use irrespective of treatment group or
motivation. Participants in the MET intervention group with high motivation showed the
least change in substance use across treatment.
Table 13.
Hypothesis 3: Final Model Retained for Mixed Linear Model of Treatment Group, Time,
Motivation and All Interactions.
Variable
Treatment group
Time
Motivation
Treatment Group X Time
Treatment Group X Motivation
Time X Motivation
Treatment Group X Time X Motivation

F
23.104
.676
.035
1.123
.012
.932
3.963

Note. *p <.05, **p <.01, ***p<.001
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p
.411
.000***
.851
.289
.913
.335
.047*

MET-High = motivational enhancement therapy with high motivation at baseline; MET-Low
= motivational enhancement therapy with low motivation at baseline; TAU-High = treatment
as usual with high motivation at baseline; TAU-Low = treatment as usual with low
motivation at baseline.
Figure 10. Hypothesis 3: Three-way Interaction of Time X Treatment Group X Motivation
Logistic regression was performed to assess the effects of Treatment Group and
Motivation on treatment retention at study completion. As seen in Table 14, the full model
was nonsignificant, χ2(2,451) = .658, p = .720, indicating that retention of participants at
treatment completion could not be predicted by treatment group or motivation.
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Table 14.
Hypothesis 3: Logistic Regression for Predicting the likelihood of Being Active in Treatment
at Study Completion
β
Treatment .30
Group
Motivation -.163
Constant
.951

S.E.

Wald χ2

df

p

.208

.021

1

.208
.183

.610
26.864

1

Lower

Upper

.884

Odds
Ratio
1.03

.685

1.551

.435
.000

.85
2.588

.565

1.278

Note. *p <.05, **p <.01, ***p<.001
Taken together, Hypothesis Three was not supported by study findings as participants
with low motivation, regardless of intervention condition, generally reported similar
reductions in substance use over the course of treatment to those with high motivation.
Motivation at baseline and treatment group were also unable to predict participation in
treatment at study completion.
Exploratory Analysis
While replicating the analyses and outcomes obtained in the original study by Ball
and colleagues (2007) it became clear that time was not a linear variable. Instead, there
appeared to be 2 phases: intervention phase (experimental [weeks 0-4]); followed by postintervention phase (retention [weeks 5-16]). This finding prompted a reanalysis of the data,
adding phase as an additional covariate.
An exploratory analysis was run with the most parsimonious model using the
variables Treatment Group, Phase, Time and Legal Status and all possible two, three and
four-way interactions. As shown in Table 15, a significant main effect was observed for
Treatment Group, F(1,685.30) = 5.849, p = .016, Phase , F(1,5177.957) = 68.629, p < .001,
Time , F(1,5259.41) = 106.888, p < .001, and Legal Status, F(1,696.123) = 7.123, p = .008.
73

Significant two-way interactions were seen for Treatment Group X Phase , F(1,5135.89) =
4.305, p = .038, Treatment Group X Time, F(1,5191.01) = 15.812, p < .001, Treatment
Group X Legal Status, F(1,686.70) = 5.097, p = .024, and Phase X Time, F(1,5243.77) =
93.098, p < .001. Significant three-way interactions were seen for Treatment Group X Phase
X Time, F(1,5179.21) = 15.130, p < .001, and Treatment Group X Time X Legal Status,
F(1,5199.99) = 9.956, p = .002.
In addition, the four way interaction for Treatment Group X Phase X Time X Legal
Status was significant, F(1,5187.74) = 7.263, p = .007 and is shown in Figure 11. To better
understand this interaction, the two graphs (Figures 12 & 13) represent the three way
interaction between Treatment X Time X Phase separated by the fourth variable, Legal
Status. For those participants with legal incentives we see an initial difference in their
response to the intervention, however following the intervention both groups showed similar
reductions in substance use (See Figure 12). Entering treatment without legal incentives had
similar reductions in substance use during the intervention phase regardless of group
assignments, however participants in the MET condition showed an initial increase in
substance use immediately post intervention. This initial increase in substance use postintervention was also seen for TAU but in a gradual increase over the full 12 weeks post
intervention (See Figure 13).
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Table 15.
Exploratory Analysis: Final Model Retained for Mixed Linear Model of Treatment Group,
Phase, Time, Legal Status and All Interactions
Variable
Treatment Group
Phase
Time
Legal Status
Treatment Group X Phase
Treatment Group X Time
Treatment Group X Legal Status
Phase X Time
Phase X Legal Status
Time X Legal Status
Treatment Group X Phase X Time
Treatment Group X Phase X Legal Status
Treatment Group X Time X Legal Status
Phase X Time X Legal Status
Treatment Group X Phase X Time X Legal Status

Note. *p <.05, **p <.01, ***p<.001

75

F
5.849
68.629
106.888
7.123
4.305
15.812
5.097
93.098
.137
1.498
15.130
.039
9.657
.072
7.263

P
.016*
.000***
.000***
.008**
.038*
.000***
.024*
.000***
.712
.221
.000***
.844
.002**
.788
.007**

MET-L = motivational enhancement therapy with legal involvement; MET-NL =
motivational enhancement therapy with no legal involvement; TAU-L = treatment as usual
with legal involvement; TAU-NL = treatment as usual with no legal involvement .
Figure 11. Exploratory Analyses: Four-Way Interaction of Treatment Group X Phase X
Time X Legal Status
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MET-L = motivational enhancement therapy with legal involvement; TAU-L = treatment as
usual with legal involvement.
Figure 12. Exploratory Analysis: Three-Way Interaction of Treatment X Time X Phase
Separated by Legal involvement
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MET-NL = motivational enhancement therapy with no legal involvement; TAU-NL =
treatment as usual with no legal involvement .
Figure 13. Exploratory Analysis: Three-Way Interaction of Treatment X Time X Phase
Separated by No Legal Involvement
Given the complexity of a four-way interaction and to further parse out the effect of
Phase, A mixed linear model was conducted with only the intervention phase. This model
was fit to test the following variables; Treatment Group (MET, TAU), and Time (mean
weekly use prior to entry into treatment, week 1, week 2, week 3, week 4) and legal status at
treatment entry (no legal involvement, legal involvement). The model tested the Treatment
Group, Time and Legal Status variables. All interactions terms were assessed for the
intervention phase of treatment: Treatment Group, Time, Legal Status, Treatment Group X
Time, Treatment Group X Legal Status, Time X Legal Status and Treatment Group X Time
X Legal Status. None of the additional covariates added to previous models contributed
significantly to the model and therefore, they were not retained. To create the most
parsimonious model, the analysis was run with the three primary variables, Treatment Group,
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Legal Status, Time and all potential interactions. As shown in Table 16, Main effects for the
most parsimonious full model included Treatment Group F(1,679.12) = 4.544, p = .033,
Time F(1,1423.85) = 73.358, p < .001, and Legal Status F(1,690.09) = 5.194, p = .023, as
well as a significant 2 way interaction for Treatment Group X Time F(1,1396.91) = 10.628, p
= .001.
Table 16.
Exploratory Analysis: Final Model Retained for Mixed Linear Model of Treatment Group X
Time X Legal Status and All Interactions for the Intervention Phase.
Model without covariates
F
4.544
73.358
5.194
10.628
3.512
.707
6.248

Variable
Treatment group
Time
Legal Status
Treatment Group X Time
Treatment Group X Legal Status
Time X Legal Status
Treatment Group X Time X Legal Status

P
.033*
.000***
.023*
.001**
.061
.400
.013*

Note. *p <.05, **p <.01, ***p<.001
In addition, a significant three-way interaction for Treatment Group X Time X Legal
Status was found, F(1,1400.70) = 6.248, p = .013, and is shown in Figure 14. Participants
entering treatment without legal incentives had similar reductions in substance use regardless
of intervention group assignment (MET or TAU). In contrast, participants with legal
incentives responded differently based on intervention group assignment. Those receiving
MET showed a more modest decrease in substance use over time as opposed to those in the
TAU intervention group. Participants with legal involvement generally reported greater
substance use over the intervention period than those without legal involvement.
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MET-L = motivational enhancement therapy with legal involvement; MET-NL =
motivational enhancement therapy with no legal involvement; TAU-L = treatment as usual
with legal involvement; ; TAU-NL = treatment as usual with no legal involvement .
Figure 14. Exploratory Analysis: Three-Way Interaction of Treatment Group X Time X
Legal Status
A similar mixed linear analysis was run for the variables, Treatment Group, Time,
Legal Status and all interaction terms for the 12 week post intervention phase (weeks 5-16)
of the study: Treatment Group, Time, Legal Status, Treatment Group X Time, Treatment
Group X Legal Status, Time X Legal Status and Treatment Group X Time X Legal Status.
As with previous models, potential covariates were first tested in the model. When found to
be nonsignificant, the covariates were eliminated from the model (Model 1). The most
parsimonious model is presented below (Model 2) and is shown in Table 17.
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Table 17.
Exploratory Analysis: Final Model Retained for Mixed Linear Model of Post-Intervention
Phase for Treatment Group, Time, Legal Status and All Interactions.
Variable
Treatment Group
Time
Legal Status
Treatment Group X Time
Treatment Group X Legal Status
Time X Legal Status
Treatment Group X Time X Legal
Status

Model 1
F
.250
2.971
1.991
.000
1.228
21.511
1.752

p
.671
.085
.159
.993
.268
.000***
.186

Model 2
F

p

5.536
.815

.019*
.367

25.817

.000***

Note. *p <.05, **p <.01, ***p<.001
A significant main effect was observed for Time F(1,3337.16) = 5.536, p = .019. A
significant 2-way interaction was found between Time X Legal Status, F(1,3334.895) =
25.817, p < .001, and is shown Figure 15. During the post-intervention period, as shown in
Figure 16, participants entering treatment with legal incentives continued to show
comparable rates of decline in substance use regardless of intervention group assignment. In
contrast, participants without legal incentives showed a different response with an increase in
substance use over the 12-week post intervention period.
Overall, the data support the role of legal incentive, irrespective of treatment group,
for sustained reductions in substance use over the post-intervention period.
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Legal = any legal involvement; No Legal = no legal involvement
Figure 15. Exploratory Analysis: Two-way Interaction of Time X Legal Status
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MET-L = motivational enhancement therapy with legal involvement; MET-NL =
motivational enhancement therapy with no legal involvement; TAU-L = treatment as usual
with legal involvement; TAU-NL = treatment as usual with no legal involvement .
Figure 16. Exploratory Analysis: Days Using Primary Substance per Week Separated by
Treatment Group and Legal Status during the Post-Intervention Phase
Discussion
The present study examined whether individuals with and without legal incentives to
enter substance abuse treatment differed in their response to MET, a brief motivational
intervention to improve engagement and early retention in substance abuse treatment. Using
data from a multisite clinical trial of MET (CTN-0004), the present study first compared
participants with and without legal incentives to enter treatment on a variety of baseline
demographic and substance use characteristics. Second, mixed linear models and logistic
regression were used to determine whether type of intervention and legal status interacted in
predicting outcomes of substance use (greater reduction in days per week of substance use)
and treatment retention (higher rates of treatment retention at 16 weeks). Third, Readiness to
change scores (high/low) were compared for participants with and without legal incentives
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to enter treatment. In addition, the study examined whether level of motivation (readiness to
change) at study enrollment predicted treatment across the two Treatment and Legal Status
groups.
Summary of Findings
When participants randomized to either MET or TAU are further subdivided into
those with and without legal incentives to enter substance abuse treatment, it was
hypothesized that those in the MET with legal incentives group will have the most positive
treatment outcomes (greater reduction in days per week of substance use; higher rates of
treatment retention at 16 weeks) over time relative to the other three participant subgroups.
The hypothesis that when participants randomized to either MET or TAU are further
subdivided into those with and without legal incentives to enter substance abuse treatment,
that those in the MET with legal incentives group will have the most positive treatment
outcomes over time relative to the other three participant subgroups was not supported by the
data. Similarly, treatment retention rates were higher for participants with legal incentives
regardless of intervention group assignment. Given variability across groups in baseline
rates of primary substance use, additional analyses, controlling for baseline use, were
performed and in all cases interactions remained statistically significant. Thus, the observed
findings could not be explained by the variability in baseline rates of primary substance use.
While findings confirm the positive relationship between legal incentives to enter treatment
and measures of treatment outcome, they do not support motivational interventions further
strengthening this association.
The hypothesis that when participants randomized to either MET or TAU are further
subdivided into those with primary alcohol or primary drug and with and without legal

84

incentives to enter substance abuse treatment, those in the MET intervention presenting with
primary alcohol problems and legal incentives will have the most positive treatment
outcomes over time relative to the other participant subgroups was not supported.
Reductions in primary substance use were generally uniform across all participants with a
legal incentive to enter treatment, but were weakest in the MET with primary alcohol use
group. Participants in the MET group with primary drug use and no legal incentive to enter
treatment actually showed an increase in substance use over the 16 week study period. Once
again these results suggest that legal status and not treatment intervention most impacts
substance use.
The hypothesis that participants in the MET intervention with low baseline
motivation to change would show greater reductions in substance use and higher treatment
retention than participants in the other 3 groups was also not supported. Rather, baseline
motivation, as measured by the URICA Readiness to Change score, was not associated with
either measure of treatment outcome.
Discussion of Findings
Legal Status. The present study found participants with legal incentives to enter
treatment had a more positive outcome than participants without legal incentives for care.
This is consistent with much of the literature, that is, legal incentives have been associated
with better treatment retention (Brocato, 2004; Broome et al., 1999; Simpson & Joe, 2004;
Simpson et al., 1997) and lower rates of substance use (Howard & McCaughrin,1996). Not
all studies have found such relationships, however, several studies have found no change in
substance use (Brecht, Anglin, and Wang, 1993; Hser, Anglin, and Liu, 1991) and lower
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retention rates (Grichting, Uchtenhagen, and Rehm, 2002; Howard & McCaughrin, 1996) for
participants with legal incentives prompting further study.
Some of the variability across studies may stem from how legal encouragement to
enter treatment is defined and measured. Defining “legal incentive to enter treatment” was
challenging. The present study defined it as being mandated or referred as alternative to jail,
referred by probation/parole officer, referred by other federal, state, private agency or other
legal issues involved. Using this definition we found that approximately one third (37.3%) of
participants were categorized as having legal incentive to enter treatment. These findings
were consistent with previous research which showed that between 34% (Niv, Hamilton,
Hser, 2009) and 42% (Craddock, Rounds-Bryant, Flynn, & Hubbard, 1997) of the clients
enrolled in publicly funded outpatient drug abuse treatment programs are referred by the
criminal justice system. Further, the variable was highly correlated with other measures of
legal involvement from the Addiction Severity Index including an 84% correlation with “was
the treatment admission prompted by the legal system” (y/n). Demographically, participants
with legal incentives were generally younger, less likely to be employed and reported less
education than those without legal incentives. Additionally, a significantly higher proportion
of participants with legal involvement were primary drug users (71.5%). While it is likely
that this is a result of the illicit nature of drug use, the legal status variables did not specify
the event or events that initiated contact with the legal system (except that they were criminal
and not civil).
Motivation for substance abuse treatment is a dynamic construct with a complex
myriad of psychosocial problems (Joe, Simpson, & Broome, 1998) and the absence of legal
motivation does not preclude an individual from having other extrinsic motivations (e.g. job,
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family). Variability across previous studies may come from the fact that when one measures
“legal incentive to enter treatment”, it is often used as a proxy for extrinsic motivation to
enter treatment. Further, this is often used as an absolute measure of patient motivation.
That is, based solely on a person’s legal status, he/she may be categorized as intrinsically or
extrinsically motivated to enter treatment. In this scenario, if a person has a legal reason to
seek substance abuse treatment, it is then assumed that he/she cannot be internally selfmotivated to enter care. Clearly a variety of factors can contribute to a person’s decision to
enter substance abuse treatment. Marlow and colleagues (1996) identified four dimensions
of the pressure to enter treatment; the external or internal nature of pressure, the negative or
positive quality of the pressure, whether pressure is coercive or noncoercive and the
psychosocial life domain from which the pressure emanates. Additionally these factors can
come from a variety of sources, such as family members, friends, employers, the legal
system, and/or health care providers (Marlow et al., 1996). The belief that someone with
legal pressure to seek treatment enters care primarily because of such external factors while
oversimplified, has guided many segments of the addiction treatment community. The
majority of people coming to treatment have some external factors likely to be motivating
them into treatment. Legal incentive is one that can more easily be measured and tied to
clearer consequences than other forms of external motivation.
Some studies find legally pressured clients do better in substance abuse treatment
than voluntary clients (Kelly, Finney & Moos, 2005) while others report the opposite (Kelley
et al., 2005). The present study hypothesized that if legal incentives to enter treatment create
a state of high extrinsic motivation, patients in this group may benefit more from an
intervention designed to focus specifically on stages of change and guiding a person toward
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greater self-motivation (internal) to change behavior. This was not the case as rates of
substance use were comparable for MET and TAU.
According to Ryan et al. (1995), legal status can be interpreted as an internal or
external motivation based on the perception of these events by the individual as either being
controlling or informative. Events perceived to be controlling will be attributed to external
forces whereas informative events will be interpreted as internally motivating. Individual
interpretation is the ultimate decision in how legal incentive is interpreted regardless of how
it may seem to outside observers. As such, it is important to recognize that the underlying
motivation is not clear and is likely more complex and not unidemensional.
Client legal status, including pressure to enter treatment, effects the length of
treatment stay as clients with legal involvement are more likely to, stay in treatment for
longer periods of time (Hubbard et al., 1989; Simpson, 1993), and successfully complete
treatment (Hser et al., 2004; Maglione, Chao, & Anglin, 2000) than those without legal
involvement. This was supported by the current study as legal status was found to
significantly impact treatment retention. Participants with legal incentives are almost twice
as likely as those without legal incentive to still be in treatment at study completion.
Retention within the current study was exceptionally high for an outpatient substance abuse
programs. It is this higher retention overall that may have resulted in not seeing a main effect
for MET. Given these higher rates of retention, it is possible that a ceiling effect may be
leading to the mistaken conclusion that MET had no effect. These higher rates of retention
may be the results of many things, including, exceptional programs with well trained staff (in
part due to the training and oversight of the CTN) or because of enhanced attention as a
result of being a part of this study.
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Treatment retention is one of the strongest predictors of abstinence at twelve month
follow up (Simpson, Joe, Brown, 1997). Treatment retention is also a potent and consistent
predictor of positive treatment outcomes such as decreases in drug and alcohol use (Chou et
al., 1998; Etheridge, Hubbard, Anderson, Craddock, & Flynn, 1997), decreases in criminal
activity (Etheridge, Hubbard, Anderson, Craddock, & Flynn, 1997; Hser, Evans, Huang, and
Anglin, 2004; Roffman, Klepsch, Wertz, Simpson, & Stephens, 1993) and improved social
functioning (Hser, Evans, Huang, and Anglin, 2004; Roffman, Klepsch, Wertz, Simpson, &
Stephens, 1993; Simpson & Joe, 2004; Simpson, Joe, and Rowan-Szal, 1997; Simpson &
Sells, 1982). The present study and much of the existing literature supports the fact that
patients with legal incentives to enter treatment are retained in treatment longer than
participants who are not legally incentivized. Given that participants in this study with legal
incentives to enter treatment are almost twice as likely to still be in treatment at 16 week post
enrollment, it was not surprising that they also reported lower rates of primary substance use.
It was somewhat surprising that the type of intervention (MET or TAU) made no difference.
It is possible legal incentives, as they were measured in the current study, were so compelling
that they overshadowed any potential treatment effects. It is also worth noting that the
overall retention rates of the current study were higher (69%) than is normally seen in an
outpatient treatment program (25-40%) (Justus et al., 2006; Sayre et al., 2002; Siqueland et
al., 2002; Wickizer et al., 1994) and this potentially made it more difficult to observe any
treatment effects that may have been present.
Motivation. In psychology, motivation is often defined as “the process that initiates,
guides and maintains goal-oriented behaviors” (“Merriam-Webster's”, 2003). In the field of
addiction, it is considered by many to be integral to the recovery process. A client’s level of
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motivation at treatment onset has also been found to be positively associated with therapeutic
participation and therapeutic alliance (Brocato, 2004; Brocato & Wagner, 2008; Joe et al.,
1999), which also appears to be related to increased retention and engagement (Brocato &
Wagner, 2008; Simpson, Joe, Rowan Szal, & Greener, 1997). In traditional 12-Step focused
recovery programs, motivation is often viewed as a trait; something an individual possesses
when he/she enters drug abuse treatment. In contrast, the principles of motivational
interviewing that form the basis for MET view motivation as a state that is subject to change
and that therapists can help to guide individuals in the direction of change.
In contrast to such internal motivation, legal issues that prompt (or even require) that
a person seek drug abuse treatment, are seen as a marker for extrinsic motivation to seek
care. Some might argue such external pressure to enter treatment undermines internal selfmotivation (Brecht, Anglin, & Wang, 1993; Shearer & Ogan, 2002) such that persons with
strong external pressure to enter treatment are, for all practical purposes, incapable of being
self-motivated to change. The present study explored this issue using a categorical measure
that classified participants as having either high or low motivation to change based on
URICA Readiness to Change scores.
While the present study affirmed a relationship between legal incentives to enter
treatment and low readiness to change, with nearly three-fourths of legally incentivized
participants categorized as low readiness to change (71.4%), it was not absolute. That is
more than one fourth (28.6%) of those entering treatment with legal pressure to do so
nonetheless reported high motivation to change. This is an interesting group that warrants
further study. In particular, it would be important to compare the congruent and incongruent
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cases so that demographic and psychosocial correlates may be identified. Such correlates
may be useful in treatment planning and relapse prevention.
For the sake of simplicity, a mean separated readiness to change score was used
(high readiness to change, low readiness to change) to establish participants baseline
motivation. The findings from the current study showed that the dichotomous Readiness to
Change score had comparable cut off scores to the ATCC algorithm. The ATCC algorithm
(Callahan, Taylor, Moore, Jungerman, Vilela & Bundy, 2008) suggests that precontemplation
range from -2 to 10.15. The mean separation resulted in a low motivation (comparable to
precontemplation) ranging from -2 to 10.16. Using mean separation, a total of 225
participants were categorized as low motivation, while 226 were categorized as high
motivation. The decision to mean separate the Readiness to Change score into high and low
resulted in an almost identical split point, suggesting that using the mean separation scores
was appropriate.
Using the URICA readiness to change score as a measure of motivation, the current
study looked at level of substance use and treatment retention. The readiness to change score
is based on the Transtheoretical Model of Change (discussed in greater detail in the literature
review) and attempts to classify individuals through the stages of change; precontemplation,
contemplation, preparation, action (Callahan, Taylor, Moore, Jungerman, Vilela & Bundy,
2008). Greater treatment gains were predicted for individuals in the MET condition who had
low motivation scores but this was not the case. Instead, the readiness to change score was
not predictive of treatment outcome as measured by substance use and retention. The existing
body of research focused on the predictive validity of the URICA readiness to change score
has found mixed results. There is a growing body of research to suggest that the URICA is
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not an adequate tool for use as a predictive measurement (Callahan, Taylor, Moore,
Jungerman, Vilela & Bundy, 2008; Blanchard et al., 2003; Callaghan et al., 2007;
Diclemente et al., 2004; Kinnaman, Bellack, Brown, & Yang, 2007; Pantalon, Nich,
Frankforter, & Carroll, 2002; Pantalon & Swanson, 2003). Additionally, several studies have
shown that readiness to change scores were not related to changes in frequency or intensity
of substance use and that baseline scores could not predict subsequent improvements in drug
use outcomes (Callahan, Taylor, Moore, Jungerman, Vilela & Bundy, 2008; Blanchard et al.,
2003; Callaghan et al., 2007; Diclemente et al., 2004; Kinnaman, Bellack, Brown, & Yang,
2007; Pantalon, Nich, Frankforter, & Carroll, 2002). Findings from the current study show
that baseline motivation does not result in different outcomes in substance use or treatment
retention.
Given the existing body of research in support of motivation at treatment outset being
predictive of treatment participation it was surprising that no predictive effects were present
in the current study. This suggests the possibility that the URICA measure may assess
readiness to change but not readiness for treatment. Readiness for treatment is different from
readiness to change in that it suggests an openness to treatment participation. A large body
of research has focused on readiness for treatment rather than readiness to change, and
although these two constructs are likely related, they remain distinct (DiClemente et al.,
1999). For example, a client may want to change a specific behavior but may not be open to
the idea of treatment assisting in that process. Although measurement of readiness to change
from the URICA was not found to be predictive, it does not mean that motivation is not
related to decreases in substance use and retention in treatment. It may be that the measure
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used in the current study (URICA Readiness to Change score) did not adequately assess the
clients’ motivation for treatment.
Study Strengths, Limitations, and Future Directions
Strengths. The current study has a number of strengths. First, this was a large multisite study with a heterogeneous group of community treatment programs. As part of the
NIDA CTN, these were actual programs that typically did not participate in randomized
clinical trials. This is important, because previously conducted clinical trials have been
limited by so many inclusion/exclusion criteria, that final study participants bore little
resemblance to the substance abuse patients served by programs through the USA. The
present study kept exclusion criteria to a minimum, making every effort to maintain study
representativeness and generalizability.
Secondly, study assessments used standardized measures with well established
reliability and validity. Staff training in their administration was rigorous with ongoing
monitoring for fidelity throughout the study. For this study, in particular, data were
abstracted from the Addiction Severity Index (ASI ‘lite’) and the Substance Use Calendar,
both of which have been shown to be reliable and valid for measuring changes in substance
use and other outcomes over time (McLellan, et al., 1992; Sobell & Sobell, 1992; Miller and
Dleboca, 1994; Fals-Stewart et. al. 2000). This ensured that information was gathered
accurately and consistently with minimal experimenter error across participating study sites.
Third, both MET and TAU were delivered by actual therapists from the participating
treatment programs. None had prior allegiance to, or experience with, MET. Therapist
training was rigorous with certification and careful fidelity monitoring of both the
experimental (MET) and control (TAU) interventions.
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Fourth, a randomized clinical trial was used to compare MET and TAU in the context
of ongoing outpatient substance abuse treatment. Urn randomization was used to minimize
chance differences in demographic and other variables between study groups.
Finally, the data set had been carefully monitored throughout study administration.
At study completion, quality assurance procedures were in place to review files for data
accuracy. In addition, prior to testing current study hypotheses, a rigorous set of procedures
were undertaken to replicate not only the descriptive tables for the primary outcome paper,
but also the main study results. Ultimately, this effort brought to light the difference in the
pattern of findings over the course of the 16 week study period. That is, one of the primary
outcome variables (days of substance use), when examined concurrently for the 4 study
groups (legal incentive/MET; legal incentive/TAU; no legal incentive/MET; no legal
incentive/TAU) showed a different pattern during the initial phase (weeks 1-4) as compared
to what was seen in the subsequent phase (weeks 5-16). In fact, not only was the pattern of
use dissimilar for the two phases, but in some cases the trend was an opposite direction.
When data were analyzed as originally proposed, hypothesis testing yielded negative results.
However, in the exploratory analyses that arose following replication of the primary paper
results, significant interactions were found between MET and the presence or absence of
legal incentives to enter treatment.
Clearly, further research is needed to better understand the interactions that were
found and the different patterns of substance use found across the 4 groups of participants in
the 2 phases of the study. Since the first phase could be considered treatment engagement
(weeks 1-4) and the second phase might be considered early treatment retention (weeks 516), this is worthy of study as these are the two targets of MET. Since this was the first time
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research had been blended with ongoing clinical practice at these sites, the varied patterns
could in part be the result of increased time and attention contributed by the presence of RAs
and more frequent monitoring and assessment.
Limitations. It is important to also recognize the limitations of this study. First, as a
secondary data analytic study, testing of the hypotheses for the present study was done within
the confines of available measures and how information was entered into the computer
database for analysis. In some cases, creation of new variables presented problems or
required modifications to proposed analyses. Related to this, a second limitation was the
focus on primary substance used. While this categorization was supported in the literature
(Ball et al., 2007; Carroll et al. 2006) it does not tell the full story. Types of substances used
can change for a number of reasons (e.g. being drug tested and fearing consequences,
availability) and by focusing on only the primary substance used at study enrollment we
potentially missed changes in substance used. A third limitation was sample size. Clearly
an N of 461 was sufficient for the primary clinical trial comparing MET to TAU, as well as
subsequent comparisons of participants with primary alcohol versus other drug(s). The
present study, however, proposed further sub grouping and further reductions in cell counts
created limitations in variables that could be created to capture legal incentives to enter
treatment and baseline levels of motivation to change.

Related to this, the fourth limitation

was the use of a dichotomous variable to represent legal incentive to enter treatment.
Clearly, a more refined measure was preferred, and a 3-category variable was considered
(mandated to treatment, other legal involvement, no legal involvement, reductions in
subgroup sample sizes made this less feasible. Nonetheless, while using a trinomial variable
seemed to have merit, there was nonetheless also support in the literature for the
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dichotomous measure used in this study (Niv, Hamilton, Hser, 2009; Craddock, RoundsBryant, Flynn, & Hubbard, 1997).
A fifth limitation is the better than expected overall outcomes for all study
participants. For example, while between 60-75% of outpatients in substance abuse
treatment tend to drop out during the first few months of care (Justus et al., 2006; Sayre et al.,
2002; Siqueland et al., 2002; Wickizer et al., 1994), only one-third (31%) did so in the
current study sample. This may have created a ceiling effect for the outcome variable of
treatment retention, measured at 16 weeks post-study enrollment. It is unclear why the
current study had higher rates of participant retention than traditional outpatient programs
report. It is possible that in this study the retention was higher because of the additional
focus and attention provided because of the research study (e.g. study visits, contact with the
RA).
Future Directions. While much of the research has focused on client characteristics,
future directions should also focus on programmatic factors. Multi-site trials, such as this,
lend themselves to just such an assessment of programmatic factors. Clearly not all
programs and not all treatments are created equally. A focus on programmatic factors
associated with improved retention and decreases in primary substance use for legally
involved clients could be an important step towards gaining a better understanding of the
predictors of treatment retention, while also helping to provide a more complete picture of
the occurrence of substance treatment drop-out among this population.
More than one fourth of those entering treatment with legal pressure did so while
reporting high motivation to change. This is an interesting group that warrants further study.
Measures, such as the URICA, are useful but they may not tell the whole story. While
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qualitative approaches are seldom employed within substance abuse treatment research they
may provide a better way to understand the characteristics of this group. Employing a
qualitative component to a quantitative investigation could prove quite useful in determining
factors related to retention.
From the current study it appears that the role of legal incentives didn’t strengthen
MET. Theory suggests that a motivationally enhancing program, with exceptional training
and fidelity monitoring as seen in the CTN, should result in differences in substance use and
retention. Further research is needed to assess what, if any, role that MET can have with
this population. Findings from the exploratory analysis present one future area where this
could be assessed. Results from the exploratory analyses show a different response to MET
at different time points (intervention, post-intervention) among those with and without legal
incentives. This transition point is worth further exploration.
Consistent with many previous studies, the present study affirmed an association
between legal incentives to enter care and treatment outcomes of substance use and treatment
retention. That is, participants who were legally encouraged to enter treatment displayed a
more rapid and steeper reduction than those without legal encouragement. Legally
encouraged participants also had retention rates two times higher than those without legal
involvement. What remains unclear, however, is what happened to substance use for these
individuals after the legal incentives are no longer present. It is possible that treatment
effects may not hold if an individual is motivated to complete treatment to satisfy a court
order rather than an internal desire to alter the substance use? Research in support of this
comes from Brecht, Anglin & Whang (1993) who showed that client relapse rates can
increase significantly once monitoring probation programs end. While relapse may occur
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after the removal of legal incentives, this is not necessarily a negative outcome in all cases.
For example, from a harm reduction standpoint, reductions in substance use and engagement
in treatment during the time a person has active legal issues should not be ignored.
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